syndrome	score	normalized_score
ARTHROGRYPOSIS, DISTAL, TYPE 2A	1.8672069509999998	100.0
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	1.7064201	91.38891107309294
BEHR SYNDROME	1.56082751	83.59156488594284
MYOCLONIC EPILEPSY OF LAFORA	1.5181308	81.30490298287242
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	80.33389117348034
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	69.92024099421855
260150 PALANT CLEFT PALATE SYNDROME	1.25	66.9449093112336
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	1.1361111	60.845483645588686
ARTHROGRYPOSIS, DISTAL, TYPE 1B	1.08552129	58.13609945157066
ARTHROGRYPOSIS, DISTAL, TYPE 2E	1.0781761099999998	57.742721524390895
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.0303309	55.18032692884937
WIEACKER-WOLFF SYNDROME	1.021923051	54.73003677780333
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	1.0111111	54.15099271446532
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	1.00200401	53.66325406315393
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	1.0	53.555927448986886
SALIVARY DUCT CALCULI	1.0	53.555927448986886
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	1.0	53.555927448986886
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	1.0	53.555927448986886
TREACHER COLLINS-FRANCESCHETTI SYNDROME	1.0	53.555927448986886
FRASER-LIKE SYNDROME	1.0	53.555927448986886
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	53.555927448986886
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	50.79311639730501
#181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2;;EMD2;;EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT;;SCAPULOILIOPERONEAL ATROPHY WITH CARDIOPATHY;;MUSCULAR DYSTROPHY WITH EARLY CONTRACTURES AND CARDIOMYOPATHY, AUTOSOMALDOMINANT;;HAUPTMANN-THANNHAUSER MUSCULAR DYSTROPHYEMERY-DREIFUSS MUSCULAR DYSTROPHY, ATYPICAL, AUTOSOMAL RECESSIVE,INCLUDED;;EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE, INCLUDED;EDMD3, INCLUDED	0.9110244000000001	48.79075667065681
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.8202381	43.928612174494845
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	34.21627150958481
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.5776914000000001	30.938798706303665
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.5369281	28.755682368922376
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.5256706200000001	28.152777586783962
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.52088331	27.89638875974815
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.52087191	27.895778222175228
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.5188679	27.788451608008184
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	27.5655518379655
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.50627551	27.11405448275884
BETHLEM MYOPATHY 2; BTHLM2	0.505	27.045743361738378
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	26.777963724493443
#613710 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATIONAND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4;;BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;;STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY	0.5	26.777963724493443
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	26.777963724493443
FASCIAL DYSTROPHY, CONGENITAL	0.5	26.777963724493443
COMBINED SAPOSIN DEFICIENCY	0.5	26.777963724493443
EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO	0.5	26.777963724493443
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.5	26.777963724493443
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.5	26.777963724493443
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.5	26.777963724493443
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.5	26.777963724493443
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	26.777963724493443
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.48784720000000004	26.127109249391395
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.4845863	25.952468725573
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.47487375099999996	25.43230415598426
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	24.97681897286382
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.4484126	24.015152672811578
CENTRALOPATHIC EPILEPSY	0.4484126	24.015152672811578
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.4484126	24.015152672811578
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.43333299999999997	23.20755070925183
STUVE-WIEDEMANN SYNDROME	0.4313327	23.100422787575628
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.41226011	22.078972541271355
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.3970757	21.26575738095568
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.3921565	21.002305062648627
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.388155861	20.788047130615038
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.3859646	20.670692115477244
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	20.48400150798282
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	20.48400150798282
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	20.098136406305613
EPILEPSY, JUVENILE ABSENCE	0.3752738	20.098136406305613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.3741988	20.040563784297955
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.36197261	19.385778839680423
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.3617249	19.372512500892036
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	19.35252007317533
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	19.261325039915196
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.353958	18.9565489679885
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.35347640999999996	18.93075696888834
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.348639371	18.67170485913642
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	18.6395460778252
DUPUYTREN CONTRACTUREDUPUYTREN CONTRACTURE 1, INCLUDED	0.3464909	18.55664150213417
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.33661251999999997	18.027595699540647
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.335524261	17.96931297949094
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.334248751	17.901001858470483
HYALINE FIBROMATOSIS SYNDROME; HFS	0.333333	17.851957964353147
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.333333	17.851957964353147
CRANIOACROFACIAL SYNDROME	0.333333	17.851957964353147
CAMPTOBRACHYDACTYLY	0.333333	17.851957964353147
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.333333	17.851957964353147
PEYRONIE DISEASE	0.333333	17.851957964353147
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.32990590000000003	17.668416445392722
AICARDI SYNDROME; AIC	0.32827952	17.581314156108238
TUBEROUS SCLEROSIS	0.32591575100000003	17.454720315038077
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.3163643	16.94318349824952
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.2843137	15.226683889953025
ZUNICH NEUROECTODERMAL SYNDROME	0.272694341	14.60439834234529
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.269238361	14.419310128200138
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.265625	14.22579322863714
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	14.176569975718778
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.252191261	13.506336877384516
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.25200401	13.496308476413766
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	13.388981862246721
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	13.388981862246721
DYSTONIA 6, TORSION	0.25	13.388981862246721
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	13.388981862246721
HYPERPARATHYROIDISM 2	0.25	13.388981862246721
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	13.388981862246721
SYNPOLYDACTYLY 1	0.25	13.388981862246721
HYPEREKPLEXIA 1; HKPX1	0.25	13.388981862246721
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	13.388981862246721
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	13.388981862246721
TERMINAL OSSEOUS DYSPLASIA; TOD	0.24880950000000002	13.325223530618704
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.24709639	13.23347633574657
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.23216000000000003	12.433544116556797
FRONTOMETAPHYSEAL DYSPLASIA	0.2289519	12.261731345707702
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.2285714	12.241353315313361
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	12.019455041113973
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	12.019455041113973
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	12.019455041113973
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	12.019455041113973
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	12.019455041113973
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.20699294099999999	11.085698930648421
ROBERTS SYNDROME; RBS	0.20641791	11.054902612131505
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.2	10.711185489797378
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.2	10.711185489797378
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.1935702	10.36683158748588
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.18645015099999998	9.985510759808648
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	9.709662868537599
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.1812995	9.709662868537599
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.18105712000000002	9.696681982842513
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.17996936100000002	9.638426040756531
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.1766336	9.459776266653371
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.170862271	9.150687389445137
MICROHYDRANENCEPHALY; MHAC	0.16953211	9.079449383433664
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.168858261	9.043360775278092
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.16793797100000002	8.994073790806064
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.167582751	8.975049654257635
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.167582751	8.975049654257635
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.166667	8.926005760140297
BLAU SYNDROME	0.1666665	8.925978982176574
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.165551341	8.866255607678488
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.16172489999999998	8.661327011094658
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.16172489999999998	8.661327011094658
CHROMOSOME 1P36 DELETION SYNDROME	0.153004771	8.194312415024854
LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4	0.1526316	8.174326896022787
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.15259089	8.17214663421634
WHITE-SUTTON SYNDROME; WHSUS	0.15127551000000003	8.101700238368492
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.1480541	7.9291746381250485
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.14553090000000002	7.794042321985767
OCULODENTODIGITAL DYSPLASIA; ODDD	0.14504826099999998	7.7681941427177135
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.14413251	7.719150248600376
Contractural arachnodactyly, congenital	0.1434882	7.684643628985722
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14285699999999998	7.650839127579919
WT LIMB-BLOOD SYNDROME	0.14285699999999998	7.650839127579919
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.14285699999999998	7.650839127579919
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.14285699999999998	7.650839127579919
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.13943341	7.467485589924842
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.139073651	7.448218363021722
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.1381579	7.399174468904385
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.137883151	7.384460031393704
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.13696740000000002	7.335416137276367
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	7.1992287693663375
#259450 BRUCK SYNDROME 1; BRKS1	0.1337138	7.161166571728342
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.13339445100000002	7.144063539853438
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	7.095019645736099
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.12627551	6.762802052143818
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.12595699999999999	6.74574395369204
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	6.7435348252406975
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	6.7435348252406975
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	6.734331185552661
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.125	6.694490931123361
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.12269434100000001	6.571009224997258
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.12177859	6.52196533087992
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.12177859	6.52196533087992
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.1192983	6.389131099587472
OTOONYCHOPERONEAL SYNDROME	0.1148459	6.1506786882136035
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.11146672	5.969703569296536
LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	0.1111111	5.950658010377127
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.1111111	5.950658010377127
BETHLEM MYOPATHY 1	0.1093441	5.856024686574767
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	5.789861693804289
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.107221	5.7423200970078225
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.1070027	5.7306288380457095
CHROMOSOME 17q12 DELETION SYNDROME	0.1055556	5.65312805543428
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.10127551	5.423903865919146
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	5.404636639016027
MARDEN-WALKER SYNDROME	0.10089295100000001	5.403415563870189
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.1	5.355592744898689
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.1	5.355592744898689
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	5.355592744898689
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	5.355592744898689
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	5.355592744898689
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	5.355592744898689
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	5.355592744898689
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	5.355592744898689
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	5.355592744898689
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.09993679	5.352207474724638
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.097814951	5.238570419182207
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.09579100000000002	5.130175846265904
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.09467831	5.07058470135269
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.0940457	5.036704686089186
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0908493	4.8655185195912445
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.08973732	4.80596539938652
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.08973155099999999	4.805656435241066
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	4.756612541123729
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0880544	4.715835057964071
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0880342	4.714753228229602
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0875522	4.68893927119919
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0875522	4.68893927119919
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.086896561	4.653825916482464
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.086774351	4.647280846588923
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.0862745	4.6205108626976195
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.085398271	4.57358360594492
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.08416681999999999	4.507632105531938
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.08405331	4.501552972207204
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.08192310000000001	4.387467599996098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.08187140000000001	4.384698758546985
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.08020262	4.295325697938665
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.07911436100000001	4.237042977888958
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.07911436100000001	4.237042977888958
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.07911436100000001	4.237042977888958
CANAVAN DISEASE	0.07892711000000001	4.227014576918208
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	4.223897086381402
LISSENCEPHALY 2; LIS2	0.07819861	4.18799908377162
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.0781582	4.185834888743407
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	4.1840568319521
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.07783885100000001	4.168731856868501
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0776914	4.160834981810219
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.07692310000000001	4.119687962751164
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.07692310000000001	4.119687962751164
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07692310000000001	4.119687962751164
MCLEOD SYNDROME; MCLDS	0.07692310000000001	4.119687962751164
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.07692310000000001	4.119687962751164
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.07692310000000001	4.119687962751164
LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6	0.07692310000000001	4.119687962751164
MYOCLONUS AND ATAXIA	0.07692310000000001	4.119687962751164
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	4.119687962751164
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.075560661	4.046721278513493
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0755146	4.044254438939266
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	3.985819566499676
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	3.985819566499676
ERYTHERMALGIA, PRIMARY	0.0714995	3.8292220346388377
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	3.762919796456992
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	3.762919796456992
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.067582451	3.6194408425807114
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.0666667	3.5703969484633737
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0666667	3.5703969484633737
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.0666667	3.5703969484633737
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.06501820999999999	3.4821105376229933
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	3.436308972909345
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.06377551	3.415556586582137
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0637427	3.4137994166025365
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	3.3870857199909814
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	3.3870857199909814
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0630861	3.3786345946395318
HYPEREKPLEXIA 4; HKPX4	0.062168041	3.3294670934416426
MENTAL RETARDATION, X-LINKED 98; MRX98	0.061724451	3.3057102195845465
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.061014761	3.2677021134332747
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.06082751	3.257673712462524
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.06082751	3.257673712462524
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0605556	3.2431113202298705
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.06009901	3.2186582193159374
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.2074430725488448
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.059825909999999996	3.2040320955296187
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.059822861	3.2038688035068272
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.059822861	3.2038688035068272
ROWLEY-ROSENBERG SYNDROME	0.05943432	3.18306012989987
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.05943432	3.18306012989987
MYOTILINOPATHY	0.0588235	3.1503470982954798
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0588235	3.1503470982954798
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.0588235	3.1503470982954798
COSTELLO SYNDROME; CSTLO	0.0588235	3.1503470982954798
MYOPATHY, SCAPULOHUMEROPERONEAL	0.0588235	3.1503470982954798
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0588235	3.1503470982954798
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.056831110000000004	3.0436428040053936
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.056826871	3.0434157804289366
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.0337665554245254
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	2.9753316829849363
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	2.9753316829849363
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	2.9753316829849363
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	2.9753316829849363
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	2.9753316829849363
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.055555600000000004	2.9753316829849363
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	2.9753316829849363
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.054822861	2.9360891662618926
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.054822861	2.9360891662618926
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.054822861	2.9360891662618926
YOU-HOOVER-FONG SYNDROME; YHFS	0.05390711	2.8870452721445554
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.05390711	2.8870452721445554
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.053547351	2.8677780452414354
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.053547351	2.8677780452414354
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.053547351	2.8677780452414354
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.053547351	2.8677780452414354
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.053547351	2.8677780452414354
LISSENCEPHALY, X-LINKED, 2	0.053547351	2.8677780452414354
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.053547351	2.8677780452414354
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.053279520000000004	2.853434107636846
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.052919761	2.834166880733726
NETHERTON SYNDROME; NETH	0.0526316	2.818734151124098
CRAMPS, FAMILIAL ADOLESCENT	0.0526316	2.818734151124098
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.0526316	2.818734151124098
THROMBOCYTOPENIA 1	0.0526316	2.818734151124098
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0526316	2.818734151124098
HYDROXYKYNURENINURIA	0.0526316	2.818734151124098
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0526316	2.818734151124098
#227600 FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY	0.0526316	2.818734151124098
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.0526316	2.818734151124098
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0526316	2.818734151124098
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0526316	2.818734151124098
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0526316	2.818734151124098
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0526316	2.818734151124098
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0526316	2.818734151124098
#608837 CARNEY COMPLEX VARIANT	0.0526316	2.818734151124098
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.052191261	2.795151387587139
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.05208159	2.7892778554678808
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.05191481	2.780345797887939
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050729261000000005	2.71685262165672
LOWE OCULOCEREBRORENAL SYNDROME	0.050541351	2.7067889273297805
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.050370461000000005	2.697636754888024
PSEUDOXANTHOMA ELASTICUM; PXE	0.05028102	2.692846659181059
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.050183210000000006	2.6876083539172737
DEAFNESS, AUTOSOMAL DOMINANT 20	0.05	2.6777963724493445
#610265 DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	0.05	2.6777963724493445
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.05	2.6777963724493445
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.05	2.6777963724493445
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.05	2.6777963724493445
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.05	2.6777963724493445
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.05	2.6777963724493445
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.05	2.6777963724493445
TIETZ SYNDROME	0.05	2.6777963724493445
Temtamy preaxial brachydactyly syndrome	0.05	2.6777963724493445
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.05	2.6777963724493445
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.05	2.6777963724493445
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.05	2.6777963724493445
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.05	2.6777963724493445
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.04945471	2.648592860770686
GENITOPATELLAR SYNDROME; GTPTS	0.04945471	2.648592860770686
EPILEPSY, PYRIDOXINE-DEPENDENT	0.0491988	2.6348873633772163
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	2.5994976065189253
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	2.5994976065189253
PRIMROSE SYNDROME; PRIMS	0.048179200000000005	2.5802817397502293
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.048179200000000005	2.5802817397502293
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.048179200000000005	2.5802817397502293
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.048179200000000005	2.5802817397502293
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.047439300000000004	2.5406557090307236
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.045928	2.4597166358770695
SENGERS SYNDROME	0.04496521	2.4081535244884598
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.04496521	2.4081535244884598
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.043478300000000004	2.328520680405287
LIP, MEDIAN NODULE OF UPPER	0.043478300000000004	2.328520680405287
MAL DE MELEDA	0.043478300000000004	2.328520680405287
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.043478300000000004	2.328520680405287
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.043478300000000004	2.328520680405287
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.043478300000000004	2.328520680405287
BLEPHAROCHALASIS AND DOUBLE LIP	0.043478300000000004	2.328520680405287
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.043478300000000004	2.328520680405287
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	2.328520680405287
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.043478300000000004	2.328520680405287
SHPRINTZEN OMPHALOCELE SYNDROME	0.043478300000000004	2.328520680405287
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.043478300000000004	2.328520680405287
BAZEX SYNDROME; BZX	0.043478300000000004	2.328520680405287
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.043478300000000004	2.328520680405287
ABLEPHARON-MACROSTOMIA SYNDROME	0.043478300000000004	2.328520680405287
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.043478300000000004	2.328520680405287
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.043478300000000004	2.328520680405287
CYCLIC NEUTROPENIA	0.043478300000000004	2.328520680405287
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.043478300000000004	2.328520680405287
LIP, HAMARTOMATOUS	0.043478300000000004	2.328520680405287
BRUCK SYNDROME 2	0.0434757	2.3283814349939194
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.042689609999999996	2.286281655985545
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.0419408	2.2461784419524693
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.0410217	2.1969551890341057
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.0410217	2.1969551890341057
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.1969551890341057
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.040666961	2.1779568128867792
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.03975121	2.128912918769442
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.039391451	2.109645691866322
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.03859969	2.0672421971933845
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.0384757	2.0606017977489848
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.0384757	2.0606017977489848
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0384757	2.0606017977489848
THUMBS, CONGENITAL CLASPED	0.0384757	2.0606017977489848
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0384757	2.0606017977489848
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0384757	2.0606017977489848
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.038242910000000005	2.0481345133981352
KAPUR-TORIELLO SYNDROME	0.037883151000000004	2.0288672864950152
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.03774321	2.0213726164518766
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.03719209	1.9918568737161906
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.037111861	1.987560135212886
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.037105719999999995	1.9872312482624215
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.037105719999999995	1.9872312482624215
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.037105719999999995	1.9872312482624215
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.037105719999999995	1.9872312482624215
SYNDACTYLY, TYPE V	0.0369674	1.9798233923776776
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.0369674	1.9798233923776776
FIBROSCLEROSIS, MULTIFOCAL	0.0369674	1.9798233923776776
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	1.9777186444289325
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	1.9777186444289325
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.036467700000000006	1.9530614954314196
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0349206	1.8702051200750918
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.03484931	1.866387118007253
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0341652	1.8297489724801268
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.033610419999999995	1.8000372150499777
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.033610419999999995	1.8000372150499777
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	1.7980759969867959
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.0335738	1.7980759969867959
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.033222760999999996	1.7792757777710309
MENKES DISEASE	0.032494260999999997	1.740260284624444
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.03198301	1.712879763160222
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.03157851	1.6912163905071067
15q24 recurrent microdeletion syndrome	0.03157851	1.6912163905071067
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.03157851	1.6912163905071067
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0315261	1.6884095243495056
15q13.3 microdeletion syndrome	0.031218750999999996	1.6719491636039867
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.031218750999999996	1.6719491636039867
GITELMAN SYNDROME	0.031218750999999996	1.6719491636039867
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	1.6719491636039867
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0307189	1.6451791797126833
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.6243994798624766
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.6243994798624766
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.6243994798624766
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.0303309	1.6243994798624766
22q11.2 distal deletion syndrome	0.030302999999999997	1.6229052694866495
MYXEDEMA	0.030302999999999997	1.6229052694866495
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.030302999999999997	1.6229052694866495
HEMOCHROMATOSIS, TYPE 4; HFE4	0.030302999999999997	1.6229052694866495
Growth hormone deficiency, isolated, type IA	0.030302999999999997	1.6229052694866495
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.6229052694866495
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.6229052694866495
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.030302999999999997	1.6229052694866495
CLEFT CHIN	0.030302999999999997	1.6229052694866495
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.6229052694866495
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.030302999999999997	1.6229052694866495
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.6229052694866495
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.030302999999999997	1.6229052694866495
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.6229052694866495
BARTH SYNDROME; BTHS	0.030302999999999997	1.6229052694866495
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.030302999999999997	1.6229052694866495
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.030302999999999997	1.6229052694866495
DWARFISM, LEVI TYPE	0.030302999999999997	1.6229052694866495
ADIPOSIS DOLOROSA	0.030302999999999997	1.6229052694866495
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.6229052694866495
ANISOCORIA	0.030302999999999997	1.6229052694866495
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	1.6229052694866495
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	1.6229052694866495
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.030302999999999997	1.6229052694866495
#616000 ANALBUMINEMIA; ANALBA	0.030302999999999997	1.6229052694866495
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.6229052694866495
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.030302999999999997	1.6229052694866495
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.030302999999999997	1.6229052694866495
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.6229052694866495
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.030302999999999997	1.6229052694866495
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.030302999999999997	1.6229052694866495
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.030302999999999997	1.6229052694866495
NASAL BONES, ABSENCE OF	0.030302999999999997	1.6229052694866495
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.030302999999999997	1.6229052694866495
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.030302999999999997	1.6229052694866495
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.030302999999999997	1.6229052694866495
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.030302999999999997	1.6229052694866495
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.6229052694866495
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.6229052694866495
DIMPLES, FACIAL	0.030302999999999997	1.6229052694866495
HEMOCHROMATOSIS, TYPE 3; HFE3	0.030302999999999997	1.6229052694866495
OROFACIAL CLEFT 3	0.030302999999999997	1.6229052694866495
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.6229052694866495
SATOYOSHI SYNDROME	0.030302999999999997	1.6229052694866495
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.030232500000000002	1.6191295766014961
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.029979	1.6055531489931778
ROIFMAN SYNDROME; RFMN	0.02984691	1.5984789465364413
HUNTER-MACDONALD SYNDROME	0.02858131	1.5306985647570033
#156550 KNIEST DYSPLASIA	0.0285714	1.5301678255159838
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.0285714	1.5301678255159838
PROTRUSIO ACETABULI	0.0285714	1.5301678255159838
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.0285714	1.5301678255159838
MYOPATHY, CENTRONUCLEAR, 5	0.0285714	1.5301678255159838
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.028497710000000002	1.5262212892222682
#602398 DESMOSTEROLOSIS	0.028464271	1.5244304325643014
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.028404341	1.5212208258322837
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.02831981	1.5166936897290932
HAREL-YOON SYNDROME; HAYOS	0.02831981	1.5166936897290932
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.02748859	1.4721769317149465
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.027147420000000002	1.4539052559471757
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.026460261	1.4171038183972573
THROMBOCYTHEMIA, ESSENTIAL	0.02641052	1.414439893010017
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.409367075562049
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.409367075562049
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.409367075562049
MENTAL RETARDATION, X-LINKED 41	0.0263158	1.409367075562049
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0263158	1.409367075562049
MACDERMOT-WINTER SYNDROME	0.026000761	1.3924948697344477
HEART AND BRAIN MALFORMATION SYNDROME	0.026000761	1.3924948697344477
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.025973861	1.3910542152860699
SCHAAF-YANG SYNDROME; SHFYNG	0.025647541	1.3735778450409166
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.02514341	1.3465786417801315
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.02508501	1.3434509756171105
2p15-16.1 microdeletion syndrome	0.02508501	1.3434509756171105
HALLERMANN-STREIFF SYNDROME; HSS	0.02478814	1.32755182743533
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.024725251	1.3241837487139905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.024413461	1.307485546094671
MICROPHTHALMIA, SYNDROMIC 1	0.023969851	1.2837276011190257
RENPENNING SYNDROME 1; RENS1	0.023969851	1.2837276011190257
15q26 overgrowth syndrome	0.0238095	1.2751398545966532
MESOMELIC LIMB SHORTENING AND BOWING	0.0238095	1.2751398545966532
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0238095	1.2751398545966532
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0238095	1.2751398545966532
CAMPTODACTYLY 1; CAMPD1	0.0238095	1.2751398545966532
HYPERTRYPTOPHANEMIA; HYPTRP	0.0238095	1.2751398545966532
DIGITOTALAR DYSMORPHISM	0.0238095	1.2751398545966532
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0238095	1.2751398545966532
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.0238095	1.2751398545966532
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0238095	1.2751398545966532
SPONDYLOCAMPTODACTYLY	0.0238095	1.2751398545966532
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	0.0238095	1.2751398545966532
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.02349771	1.2584416519773336
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.02349771	1.2584416519773336
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.02349771	1.2584416519773336
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023137951	1.2391744250742136
BRANCHIOOCULOFACIAL SYNDROME	0.023063171	1.2351695128195783
CORNELIA DE LANGE SYNDROME 1	0.023063171	1.2351695128195783
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.023063171	1.2351695128195783
MEIER-GORLIN SYNDROME 1; MGORS1	0.0230541	1.2346837070016885
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0230541	1.2346837070016885
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.0230541	1.2346837070016885
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0230541	1.2346837070016885
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.0230541	1.2346837070016885
#256520 NEU-LAXOVA SYNDROME; NLS	0.0230541	1.2346837070016885
WEAVER SYNDROME	0.022694341	1.2154164800985685
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.022694341	1.2154164800985685
311450 PALLISTER W SYNDROME;;W SYNDROME	0.022694341	1.2154164800985685
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.022694341	1.2154164800985685
FRYNS SYNDROME; FRNS	0.022694341	1.2154164800985685
611961 STEVENSON-CAREY SYNDROME	0.022694341	1.2154164800985685
RECOMBINANT CHROMOSOME 8 SYNDROME	0.022694341	1.2154164800985685
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.022527561	1.2064844225186266
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0222222	1.1901305309568764
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.0222222	1.1901305309568764
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.1901305309568764
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0222222	1.1901305309568764
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.0222222	1.1901305309568764
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.1901305309568764
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.1901305309568764
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	1.1901305309568764
EPILEPSY, HOT WATER, 1	0.0222222	1.1901305309568764
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.1901305309568764
AYME-GRIPP SYNDROME; AYGRP	0.022194641	1.1886545831523099
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.02190051	1.1729021246558118
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.021799061	1.1674689293720395
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.021799061	1.1674689293720395
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.02177859	1.1663725859812313
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.02177859	1.1663725859812313
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.02177859	1.1663725859812313
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.02177859	1.1663725859812313
#603543 LIMB-MAMMARY SYNDROME; LMS	0.02177859	1.1663725859812313
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.02177859	1.1663725859812313
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.02177859	1.1663725859812313
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.02177859	1.1663725859812313
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.02177859	1.1663725859812313
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.02177859	1.1663725859812313
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.02177859	1.1663725859812313
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.02177859	1.1663725859812313
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.02177859	1.1663725859812313
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.02177859	1.1663725859812313
FIBROCHONDROGENESIS 1; FBCG1	0.02177859	1.1663725859812313
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.02177859	1.1663725859812313
FRONTONASAL DYSPLASIA 1; FND1	0.02177859	1.1663725859812313
BRACHYDACTYLY, TYPE B1	0.02177859	1.1663725859812313
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.021611810000000002	1.1574405284012894
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.02150862	1.1519140922478281
SECKEL SYNDROME 1; SCKL1	0.021059161	1.127842898652534
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.021059161	1.127842898652534
MARINESCO-SJOGREN SYNDROME; MSS	0.020937720000000003	1.1213390132672019
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.020883310000000002	1.1184250352547025
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.02087191	1.1178144976817839
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.02087191	1.1178144976817839
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.02087191	1.1178144976817839
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.020647541	1.105798207795982
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.020625	1.1045910036353546
WARBURG MICRO SYNDROME 3; WARBM3	0.020577961000000002	1.1020717863640819
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.020523551	1.0991578083515823
BAND HETEROTOPIA; BH	0.020523551	1.0991578083515823
HHHH SYNDROME	0.020523551	1.0991578083515823
COPPER DEFICIENCY, FAMILIAL BENIGN	0.020523551	1.0991578083515823
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.020523551	1.0991578083515823
Congenital disorder of glycosylation, type IIh	0.02014341	1.078799004535197
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.02014341	1.078799004535197
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.02014341	1.078799004535197
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02014341	1.078799004535197
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.02014341	1.078799004535197
FUMARASE DEFICIENCY; FMRD	0.02014341	1.078799004535197
BETA-UREIDOPROPIONASE DEFICIENCY	0.02014341	1.078799004535197
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.02014341	1.078799004535197
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.02014341	1.078799004535197
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.02014341	1.078799004535197
RING CHROMOSOME 14 SYNDROME	0.02014341	1.078799004535197
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.02014341	1.078799004535197
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.02014341	1.078799004535197
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.019849461000000002	1.0630562932174947
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.019849461000000002	1.0630562932174947
HYPERPROLINEMIA, TYPE I	0.019783651	1.0595317776320767
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.01973179	1.0567543136786448
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.01973179	1.0567543136786448
MOEBIUS SYNDROME; MBS	0.01973179	1.0567543136786448
NEPHROSIALIDOSIS	0.0196078	1.0501139142342453
THROMBOCYTOPENIA 3	0.0196078	1.0501139142342453
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	1.0501139142342453
MEGAEPIPHYSEAL DWARFISM	0.0196078	1.0501139142342453
LETTERER-SIWE DISEASE	0.0196078	1.0501139142342453
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	1.0501139142342453
KNUCKLE PADS	0.0196078	1.0501139142342453
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	1.0501139142342453
MONOPHALANGY OF GREAT TOE	0.0196078	1.0501139142342453
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	1.0501139142342453
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	1.0501139142342453
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	1.0501139142342453
VESICOURETERAL REFLUX 1	0.0196078	1.0501139142342453
#215300 CHONDROSARCOMA	0.0196078	1.0501139142342453
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	1.0501139142342453
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	1.0501139142342453
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0196078	1.0501139142342453
TOE, MISSHAPEN	0.0196078	1.0501139142342453
RAYNAUD DISEASE	0.0196078	1.0501139142342453
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	1.0501139142342453
VAN DEN BOSCH SYNDROME	0.0196078	1.0501139142342453
PACHYDERMODACTYLY, FAMILIAL	0.0196078	1.0501139142342453
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.0196078	1.0501139142342453
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	1.0501139142342453
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	1.0501139142342453
CARPAL DISPLACEMENT	0.0196078	1.0501139142342453
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	1.0501139142342453
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	1.0501139142342453
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	1.0501139142342453
TRACHEOBRONCHOMEGALY	0.0196078	1.0501139142342453
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	1.0501139142342453
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	1.0501139142342453
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	1.0501139142342453
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	1.0501139142342453
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	1.0501139142342453
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	1.0501139142342453
DOUBLE NAIL FOR FIFTH TOE	0.0196078	1.0501139142342453
THALIDOMIDE SUSCEPTIBILITY	0.0196078	1.0501139142342453
PUBIC BONE DYSPLASIA	0.0196078	1.0501139142342453
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	1.0501139142342453
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	1.0501139142342453
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	1.0501139142342453
SPINAL ARACHNOIDITIS	0.0196078	1.0501139142342453
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	1.0501139142342453
ALPORT SYNDROME, X-LINKED; ATS	0.01946092	1.042247619610538
SCALP-EAR-NIPPLE SYNDROME; SENS	0.01946092	1.042247619610538
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.018933710000000003	1.0140123991001577
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0188679	1.0104878835147397
RUIJS-AALFS SYNDROME; RJALS	0.0188679	1.0104878835147397
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.0104878835147397
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.0104878835147397
ALCOHOL DEPENDENCE	0.0188679	1.0104878835147397
ACRORENAL-MANDIBULAR SYNDROME	0.0188679	1.0104878835147397
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0188679	1.0104878835147397
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.0104878835147397
PEHO-LIKE SYNDROME; PEHOL	0.0188679	1.0104878835147397
CERVICAL RIB	0.0188679	1.0104878835147397
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.0104878835147397
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.0104878835147397
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.0104878835147397
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.0104878835147397
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0188679	1.0104878835147397
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.0104878835147397
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.0104878835147397
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.0104878835147397
DIASTEMATOMYELIA	0.0188679	1.0104878835147397
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.0104878835147397
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.0104878835147397
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0188679	1.0104878835147397
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.0104878835147397
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.0104878835147397
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.0104878835147397
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0188679	1.0104878835147397
RHEUMATOID ARTHRITIS	0.0188679	1.0104878835147397
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.0104878835147397
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0188679	1.0104878835147397
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.0104878835147397
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	1.0104878835147397
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.0188679	1.0104878835147397
PALMOMENTAL REFLEX	0.0188679	1.0104878835147397
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.0188679	1.0104878835147397
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.0104878835147397
JUMPING FRENCHMAN OF MAINE	0.0188679	1.0104878835147397
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0188679	1.0104878835147397
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.0104878835147397
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.0104878835147397
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.0104878835147397
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	1.0104878835147397
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.0188679	1.0104878835147397
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.0188679	1.0104878835147397
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0188679	1.0104878835147397
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.0104878835147397
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0188679	1.0104878835147397
TRANSSEXUALITY	0.0188679	1.0104878835147397
269800 SENILE PLAQUE FORMATION	0.0188679	1.0104878835147397
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.0104878835147397
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.0104878835147397
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.0104878835147397
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.0188679	1.0104878835147397
CARDIAC ARRHYTHMIA	0.0188679	1.0104878835147397
#615325 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R	0.0188679	1.0104878835147397
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.0104878835147397
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.0104878835147397
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.0104878835147397
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.0104878835147397
MYOPATHY, CONGENITAL	0.0188679	1.0104878835147397
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.0104878835147397
MOTION SICKNESS	0.0188679	1.0104878835147397
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0188679	1.0104878835147397
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.0104878835147397
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.0104878835147397
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.0104878835147397
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.0104878835147397
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.0104878835147397
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.0104878835147397
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	1.0104878835147397
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.0104878835147397
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.018573951000000002	0.9947451721970375
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0181579	0.972463175025959
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.017816261	0.9541663815282146
WARBURG MICRO SYNDROME 2; WARBM2	0.017658200000000002	0.9457012780797004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.01762901	0.9441379805574643
Myhre syndrome	0.017614671	0.9433700421137732
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.017614671	0.9433700421137732
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01690051	0.9051224874108773
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01690051	0.9051224874108773
PAINE SYNDROME	0.01690051	0.9051224874108773
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01690051	0.9051224874108773
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.01690051	0.9051224874108773
VICI SYNDROME; VICIS	0.016853471000000002	0.9026032701396045
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.016709909999999998	0.8949147276391003
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	0.8858552605077572
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	0.8858552605077572
METATROPIC DYSPLASIA	0.0161111	0.8628449027233726
NEMALINE MYOPATHY 2; NEM2	0.0161111	0.8628449027233726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.015981409999999998	0.8558992344925134
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.015937720000000002	0.8535593760222674
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.015625	0.8368113663904201
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.015625	0.8368113663904201
CARNOSINEMIA	0.015625	0.8368113663904201
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.015625	0.8368113663904201
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.015625	0.8368113663904201
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.8368113663904201
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	0.8368113663904201
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	0.8368113663904201
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.015625	0.8368113663904201
ROIFMAN-CHITAYAT SYNDROME	0.015625	0.8368113663904201
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	0.8368113663904201
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.015625	0.8368113663904201
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.8368113663904201
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	0.8368113663904201
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.015625	0.8368113663904201
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.015625	0.8368113663904201
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	0.8368113663904201
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.015625	0.8368113663904201
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.8368113663904201
HYDROXYLYSINURIA	0.015625	0.8368113663904201
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.015625	0.8368113663904201
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	0.8366320075893934
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.8366320075893934
CROME SYNDROME	0.015577961000000001	0.8342921491191473
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.015577961000000001	0.8342921491191473
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.015577961000000001	0.8342921491191473
KNOBLOCH SYNDROME 1; KNO1	0.015577961000000001	0.8342921491191473
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.015306371000000001	0.8197468947832768
ADAMS-OLIVER SYNDROME 2; AOS2	0.014849461000000001	0.7952766559725603
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.014849461000000001	0.7952766559725603
PELGER-HUET ANOMALY; PHA	0.0147059	0.7875881134720563
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.7875881134720563
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.7875881134720563
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.7875881134720563
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.0147059	0.7875881134720563
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.0147059	0.7875881134720563
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.7875881134720563
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.7875881134720563
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.7875881134720563
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.7875881134720563
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0147059	0.7875881134720563
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0147059	0.7875881134720563
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.7875881134720563
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.7875881134720563
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.0147059	0.7875881134720563
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.7875881134720563
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0147059	0.7875881134720563
CATARACT 17, MULTIPLE TYPES	0.014662210000000002	0.7852482550018102
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.014662210000000002	0.7852482550018102
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.014662210000000002	0.7852482550018102
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.014662210000000002	0.7852482550018102
NANCE-HORAN SYNDROME	0.014662210000000002	0.7852482550018102
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.014662210000000002	0.7852482550018102
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.014662210000000002	0.7852482550018102
PEROXISOME BIOGENESIS DISORDER 14B	0.014662210000000002	0.7852482550018102
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.01443341	0.7729946588014819
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.013933710000000002	0.7462327618552231
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.013933710000000002	0.7462327618552231
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.013933710000000002	0.7462327618552231
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.013933710000000002	0.7462327618552231
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.013933710000000002	0.7462327618552231
WARBURG MICRO SYNDROME 1	0.013933710000000002	0.7462327618552231
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.013620690000000001	0.7294686854451412
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.013620690000000001	0.7294686854451412
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.013620690000000001	0.7294686854451412
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.013573951	0.726965534952103
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.013573951	0.726965534952103
CODAS SYNDROME	0.013573951	0.726965534952103
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.013573951	0.726965534952103
PHACE ASSOCIATION	0.013573951	0.726965534952103
GAUCHER DISEASE, PERINATAL LETHAL	0.013302361	0.7124202806162326
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.013302361	0.7124202806162326
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.013302361	0.7124202806162326
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.013302361	0.7124202806162326
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.0131579	0.7046835377810245
MYOPATHY, DISTAL 3	0.0131579	0.7046835377810245
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.0131579	0.7046835377810245
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.0131579	0.7046835377810245
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0131579	0.7046835377810245
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0131579	0.7046835377810245
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.0131579	0.7046835377810245
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.013115110000000001	0.7023918796454824
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.012815961	0.6863706775050454
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.012658200000000001	0.6779216408347659
#613763 CATARACT, POSTERIOR POLAR, 2; CTPP2CATARACT, CONGENITAL LAMELLAR, INCLUDED;;CATARACT, JUVENILE, AUTOSOMAL RECESSIVE, INCLUDED	0.012658200000000001	0.6779216408347659
CATARACT 1, MULTIPLE TYPES	0.012658200000000001	0.6779216408347659
PUPILLARY MEMBRANE, PERSISTENCE OF	0.012658200000000001	0.6779216408347659
#600881 CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS	0.012658200000000001	0.6779216408347659
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.012658200000000001	0.6779216408347659
#614691 CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5; CATC5	0.012658200000000001	0.6779216408347659
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.012658200000000001	0.6779216408347659
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.012658200000000001	0.6779216408347659
CATARACT, CONGENITAL OR JUVENILECATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED	0.012658200000000001	0.6779216408347659
PHEOCHROMOCYTOMA	0.012658200000000001	0.6779216408347659
CATARACT, CRYSTALLINE ACULEIFORM	0.012658200000000001	0.6779216408347659
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.012658200000000001	0.6779216408347659
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.012658200000000001	0.6779216408347659
EDICT SYNDROME	0.012658200000000001	0.6779216408347659
CATARACT 3, MULTIPLE TYPES; CTRCT3	0.012658200000000001	0.6779216408347659
FECHTNER SYNDROME	0.012658200000000001	0.6779216408347659
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.012658200000000001	0.6779216408347659
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.012658200000000001	0.6779216408347659
CATARACT 45	0.012658200000000001	0.6779216408347659
CATARACT 7; CTRCT7	0.012658200000000001	0.6779216408347659
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.012658200000000001	0.6779216408347659
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.012658200000000001	0.6779216408347659
#615188 CATARACT, MULTIPLE TYPES	0.012658200000000001	0.6779216408347659
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.012658200000000001	0.6779216408347659
CATARACT, NUCLEAR TOTAL	0.012658200000000001	0.6779216408347659
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.012658200000000001	0.6779216408347659
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.012658200000000001	0.6779216408347659
CATARACT 44; CTRCT44	0.012658200000000001	0.6779216408347659
#115900 CATARACT 42; CTRCT42	0.012658200000000001	0.6779216408347659
%614422 CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	0.012658200000000001	0.6779216408347659
#154780 MARSHALL SYNDROME; MRSHS	0.012658200000000001	0.6779216408347659
CATARACT 13 WITH ADULT I PHENOTYPE	0.012658200000000001	0.6779216408347659
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.012386610000000001	0.6633763864988955
ADDUCTED THUMBS SYNDROME	0.012386610000000001	0.6633763864988955
RAINE SYNDROME	0.012386610000000001	0.6633763864988955
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.012386610000000001	0.6633763864988955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.012386610000000001	0.6633763864988955
MECKEL SYNDROME 12; MKS12	0.012386610000000001	0.6633763864988955
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.012386610000000001	0.6633763864988955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012386610000000001	0.6633763864988955
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.012026851	0.6441091595957754
WILLIAMS-BEUREN SYNDROME; WBS	0.01180272	0.6321056160207065
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.01180272	0.6321056160207065
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.01180272	0.6321056160207065
ARTERIAL TORTUOSITY SYNDROME	0.01180272	0.6321056160207065
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.011540451	0.6180595564845881
GERMAN SYNDROME	0.0111111	0.5950652654784382
#253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1;;LCCS;;MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE	0.0111111	0.5950652654784382
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.0111111	0.5950652654784382
NEMALINE MYOPATHY 10	0.0111111	0.5950652654784382
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.0111111	0.5950652654784382
ARTHROGRYPOSIS - HYPERKERATOSIS, LETHAL FORM	0.0111111	0.5950652654784382
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.0111111	0.5950652654784382
SPONDYLOSPINAL THORACIC DYSOSTOSIS	0.0111111	0.5950652654784382
#226730 EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMYLOSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIACUTIS CONGENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA	0.0111111	0.5950652654784382
PELVIC DYSPLASIA - ARTHROGRYPOSIS OF LOWER LIMBS	0.0111111	0.5950652654784382
GLYCOGEN STORAGE DISEASE IV	0.0111111	0.5950652654784382
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.0111111	0.5950652654784382
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0111111	0.5950652654784382
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0111111	0.5950652654784382
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0111111	0.5950652654784382
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.0111111	0.5950652654784382
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.0111111	0.5950652654784382
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0111111	0.5950652654784382
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0111111	0.5950652654784382
NEMALINE MYOPATHY 3; NEM3	0.0111111	0.5950652654784382
#615731 NEMALINE MYOPATHY 9; NEM9	0.0111111	0.5950652654784382
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0111111	0.5950652654784382
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0111111	0.5950652654784382
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0111111	0.5950652654784382
NOONAN SYNDROME 2; NS2	0.0111111	0.5950652654784382
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0111111	0.5950652654784382
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.0111111	0.5950652654784382
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0111111	0.5950652654784382
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0111111	0.5950652654784382
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.010997991	0.5890076080806108
COCKAYNE SYNDROME A; CSA	0.010997991	0.5890076080806108
BOHRING-OPITZ SYNDROME	0.010811951	0.5790440633380013
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.010811951	0.5790440633380013
GLASS SYNDROME	0.010811951	0.5790440633380013
MEIER-GORLIN SYNDROME 2; MGORS2	0.0098962	0.5300001692206641
TEEBI-SHALTOUT SYNDROME; TBSH	0.0098962	0.5300001692206641
GERODERMA OSTEODYSPLASTICUM; GO	0.0098962	0.5300001692206641
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0098962	0.5300001692206641
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0098962	0.5300001692206641
OROFACIODIGITAL SYNDROME IX; OFD9	0.0098962	0.5300001692206641
COACH SYNDROME	0.009722481	0.5206964870601535
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.009536441	0.5107329423175438
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.009536441	0.5107329423175438
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.009536441	0.5107329423175438
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.009536441	0.5107329423175438
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.009536441	0.5107329423175438
CATEL-MANZKE SYNDROME; CATMANS	0.009536441	0.5107329423175438
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009536441	0.5107329423175438
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.009195271000000001	0.4924612665497732
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.009195271000000001	0.4924612665497732
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.009195271000000001	0.4924612665497732
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.009195271000000001	0.4924612665497732
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.009195271000000001	0.4924612665497732
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.009195271000000001	0.4924612665497732
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.009195271000000001	0.4924612665497732
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.009195271000000001	0.4924612665497732
ADAMS-OLIVER SYNDROME 1; AOS1	0.008993981	0.4816809939135665
OROFACIODIGITAL SYNDROME I; OFD1	0.008993981	0.4816809939135665
BARDET-BIEDL SYNDROME 1; BBS1	0.00880673	0.4716525929428163
JOUBERT SYNDROME 14	0.00880673	0.4716525929428163
ALSTROM SYNDROME; ALMS	0.00880673	0.4716525929428163
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00862069	0.4616890482002068
COHEN-GIBSON SYNDROME; COGIS	0.00862069	0.4616890482002068
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.00862069	0.4616890482002068
MEESTER-LOEYS SYNDROME; MRLS	0.00862069	0.4616890482002068
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00862069	0.4616890482002068
WAHAB SYNDROME	0.00862069	0.4616890482002068
#614815 JOUBERT SYNDROME 18; JBTS18	0.00862069	0.4616890482002068
PSEUDODIASTROPHIC DYSPLASIA	0.00862069	0.4616890482002068
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00862069	0.4616890482002068
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00862069	0.4616890482002068
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00862069	0.4616890482002068
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00862069	0.4616890482002068
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00862069	0.4616890482002068
#614976 CARPENTER SYNDROME 2; CRPT2	0.00862069	0.4616890482002068
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00862069	0.4616890482002068
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.00862069	0.4616890482002068
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00862069	0.4616890482002068
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00862069	0.4616890482002068
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00862069	0.4616890482002068
RAHMAN SYNDROME	0.00862069	0.4616890482002068
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00862069	0.4616890482002068
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00862069	0.4616890482002068
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00862069	0.4616890482002068
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00862069	0.4616890482002068
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00862069	0.4616890482002068
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00862069	0.4616890482002068
LOEYS-DIETZ SYNDROME 3; LDS3	0.00862069	0.4616890482002068
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00827952	0.4434173724324359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00827952	0.4434173724324359
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00827952	0.4434173724324359
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00827952	0.4434173724324359
XFE PROGEROID SYNDROME; XFEPS	0.00807823	0.4326370997962294
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.00807823	0.4326370997962294
SECKEL SYNDROME 10; SCKL10	0.00807823	0.4326370997962294
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.007919761	0.4241501455293159
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.007919761	0.4241501455293159
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.007919761	0.4241501455293159
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.007919761	0.4241501455293159
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.007919761	0.4241501455293159
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.007919761	0.4241501455293159
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.007919761	0.4241501455293159
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.007718471	0.4133698728931092
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.007718471	0.4133698728931092
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.007718471	0.4133698728931092
SNEDDON SYNDROME	0.007718471	0.4133698728931092
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.007718471	0.4133698728931092
PREECLAMPSIA/ECLAMPSIA 1	0.007718471	0.4133698728931092
Fabry disease	0.007718471	0.4133698728931092
NEUROFIBROMATOSIS, TYPE I	0.007718471	0.4133698728931092
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.007718471	0.4133698728931092
KEUTEL SYNDROME; KTLS	0.007718471	0.4133698728931092
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.007718471	0.4133698728931092
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.007718471	0.4133698728931092
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.007718471	0.4133698728931092
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.007718471	0.4133698728931092
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.007191261000000001	0.3851346523827289
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.007191261000000001	0.3851346523827289
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.007191261000000001	0.3851346523827289
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.007191261000000001	0.3851346523827289
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.007191261000000001	0.3851346523827289
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.007191261000000001	0.3851346523827289
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.007191261000000001	0.3851346523827289
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.007191261	0.38513465238272887
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.007191261	0.38513465238272887
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.007191261	0.38513465238272887
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.007191261	0.38513465238272887
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.007191261	0.38513465238272887
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.007191261	0.38513465238272887
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.007191261	0.38513465238272887
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.007191261	0.38513465238272887
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00700401	0.3751062514119786
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00700401	0.3751062514119786
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.00700401	0.3751062514119786
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00700401	0.3751062514119786
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00700401	0.3751062514119786
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00700401	0.3751062514119786
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00700401	0.3751062514119786
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00700401	0.3751062514119786
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.00700401	0.3751062514119786
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00700401	0.3751062514119786
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00680272	0.3643259787757721
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00680272	0.3643259787757721
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.00680272	0.3643259787757721
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00680272	0.3643259787757721
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00680272	0.3643259787757721
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.00680272	0.3643259787757721
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.00680272	0.3643259787757721
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00680272	0.3643259787757721
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00680272	0.3643259787757721
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.00680272	0.3643259787757721
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.00680272	0.3643259787757721
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00680272	0.3643259787757721
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00680272	0.3643259787757721
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00680272	0.3643259787757721
POPOV-CHANG SYNDROME; POPCHAS	0.00680272	0.3643259787757721
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00680272	0.3643259787757721
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00680272	0.3643259787757721
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00680272	0.3643259787757721
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00680272	0.3643259787757721
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00680272	0.3643259787757721
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00680272	0.3643259787757721
LIDDLE SYNDROME 3; LIDLS3	0.00680272	0.3643259787757721
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00680272	0.3643259787757721
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00680272	0.3643259787757721
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00680272	0.3643259787757721
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00680272	0.3643259787757721
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	0.00680272	0.3643259787757721
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00680272	0.3643259787757721
STIFF-PERSON SYNDROME; SPS	0.00680272	0.3643259787757721
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.00680272	0.3643259787757721
LIDDLE SYNDROME 2; LIDLS2	0.00680272	0.3643259787757721
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00680272	0.3643259787757721
CIRRHOSIS, FAMILIAL	0.00680272	0.3643259787757721
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00680272	0.3643259787757721
NEPHRONOPHTHISIS 1	0.00680272	0.3643259787757721
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00680272	0.3643259787757721
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00680272	0.3643259787757721
LONG QT SYNDROME 13; LQT13	0.00680272	0.3643259787757721
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.00680272	0.3643259787757721
#194080 DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	0.00680272	0.3643259787757721
Polyarteritis nodosa, childhood-onset	0.00680272	0.3643259787757721
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.00680272	0.3643259787757721
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00680272	0.3643259787757721
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00680272	0.3643259787757721
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00680272	0.3643259787757721
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00680272	0.3643259787757721
#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	0.00680272	0.3643259787757721
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00680272	0.3643259787757721
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00680272	0.3643259787757721
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00680272	0.3643259787757721
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00680272	0.3643259787757721
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00680272	0.3643259787757721
POLYCYSTIC KIDNEYS	0.00680272	0.3643259787757721
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.00680272	0.3643259787757721
GLYCOGEN STORAGE DISEASE IA	0.00680272	0.3643259787757721
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00680272	0.3643259787757721
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.00680272	0.3643259787757721
LIDDLE SYNDROME 1; LIDLS1	0.00680272	0.3643259787757721
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00680272	0.3643259787757721
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.00680272	0.3643259787757721
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.00680272	0.3643259787757721
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00680272	0.3643259787757721
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00680272	0.3643259787757721
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	0.00680272	0.3643259787757721
Paragangliomas 6	0.00680272	0.3643259787757721
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00680272	0.3643259787757721
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00680272	0.3643259787757721
GLYCOGEN STORAGE DISEASE IB	0.00680272	0.3643259787757721
POLYCYSTIC KIDNEY DISEASE 2	0.00680272	0.3643259787757721
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00680272	0.3643259787757721
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.00680272	0.3643259787757721
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00680272	0.3643259787757721
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.00680272	0.3643259787757721
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00680272	0.3643259787757721
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00680272	0.3643259787757721
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00680272	0.3643259787757721
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00680272	0.3643259787757721
MARSHALL-SMITH SYNDROME; MRSHSS	0.00680272	0.3643259787757721
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00680272	0.3643259787757721
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00680272	0.3643259787757721
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00680272	0.3643259787757721
ALAGILLE SYNDROME 2	0.00680272	0.3643259787757721
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.00680272	0.3643259787757721
POLYCYSTIC KIDNEY DISEASE 3	0.00680272	0.3643259787757721
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00680272	0.3643259787757721
TRIMETHYLAMINURIA	0.00680272	0.3643259787757721
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.00680272	0.3643259787757721
#178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAHPULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA,INCLUDED;;PPH1 WITH HHT, INCLUDED	0.00680272	0.3643259787757721
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00680272	0.3643259787757721
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00680272	0.3643259787757721
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00680272	0.3643259787757721
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00680272	0.3643259787757721
#605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATIONIN PREGNANCY	0.00680272	0.3643259787757721
GAUCHER DISEASE, TYPE I	0.00680272	0.3643259787757721
SICKLE CELL ANEMIA	0.00680272	0.3643259787757721
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00680272	0.3643259787757721
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00680272	0.3643259787757721
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00680272	0.3643259787757721
#615378 ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14	0.00680272	0.3643259787757721
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00680272	0.3643259787757721
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00627551	0.33609075826539164
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00627551	0.33609075826539164
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00627551	0.33609075826539164
AICARDI-GOUTIERES SYNDROME 5	0.00627551	0.33609075826539164
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00627551	0.33609075826539164
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00627551	0.33609075826539164
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.00627551	0.33609075826539164
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00627551	0.33609075826539164
ALLAN-HERNDON-DUDLEY SYNDROME	0.00627551	0.33609075826539164
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00627551	0.33609075826539164
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00627551	0.33609075826539164
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00627551	0.33609075826539164
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00627551	0.33609075826539164
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00627551	0.33609075826539164
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00627551	0.33609075826539164
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00627551	0.33609075826539164
JACOBSEN SYNDROME	0.00627551	0.33609075826539164
PETTIGREW SYNDROME	0.005915751	0.31682353136227165
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.005915751	0.31682353136227165
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.005915751	0.31682353136227165
MUCOPOLYSACCHARIDOSIS, TYPE II	0.005915751	0.31682353136227165
PALLISTER-KILLIAN SYNDROME	0.005915751	0.31682353136227165
GLUTAMINE DEFICIENCY, CONGENITAL	0.005915751	0.31682353136227165
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.005915751	0.31682353136227165
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.005915751	0.31682353136227165
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.005915751	0.31682353136227165
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.005915751	0.31682353136227165
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.005915751	0.31682353136227165
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.005915751	0.31682353136227165
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.005915751	0.31682353136227165
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.005915751	0.31682353136227165
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.005915751	0.31682353136227165
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.005915751	0.31682353136227165
KAGAMI-OGATA SYNDROME	0.005915751	0.31682353136227165
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.005915751	0.31682353136227165
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.005915751	0.31682353136227165
ZTTK SYNDROME; ZTTKS	0.005915751	0.31682353136227165
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.005915751	0.31682353136227165
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.005	0.2677796372449344
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.005	0.2677796372449344
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.005	0.2677796372449344
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.005	0.2677796372449344
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.005	0.2677796372449344
BUSCHKE-OLLENDORFF SYNDROME; BOS	0.005	0.2677796372449344
GROWTH FACTORS, COMBINED DEFECT OF	0.005	0.2677796372449344
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.005	0.2677796372449344
Ullrich congenital muscular dystrophy 1	0.005	0.2677796372449344
TEMPLE SYNDROME	0.005	0.2677796372449344
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.005	0.2677796372449344
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.005	0.2677796372449344
#300696 MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMAEMERY-DREIFUSS MUSCULAR DYSTROPHY 6, X-LINKED, INCLUDED; EDMD6, INCLUDED	0.005	0.2677796372449344
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.005	0.2677796372449344
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.005	0.2677796372449344
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.005	0.2677796372449344
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.005	0.2677796372449344
MAJEED SYNDROME	0.005	0.2677796372449344
MECKEL SYNDROME 13; MKS13	0.005	0.2677796372449344
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.005	0.2677796372449344
#168400 PARASTREMMATIC DWARFISM	0.005	0.2677796372449344
SALIH MYOPATHY; SALMY	0.005	0.2677796372449344
MARFAN SYNDROME; MFS	0.005	0.2677796372449344
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.005	0.2677796372449344
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.005	0.2677796372449344
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.005	0.2677796372449344
CZECH DYSPLASIA, METATARSAL TYPE	0.005	0.2677796372449344
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.005	0.2677796372449344
NEMALINE MYOPATHY 4	0.005	0.2677796372449344
ANAUXETIC DYSPLASIA 2; ANXD2	0.005	0.2677796372449344
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.005	0.2677796372449344
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.005	0.2677796372449344
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.005	0.2677796372449344
#614594 PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTICPLAQUES;;OLMSTED SYNDROME; OLMS	0.005	0.2677796372449344
RIGID SPINE MUSCULAR DYSTROPHY 1	0.005	0.2677796372449344
#613723 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q	0.005	0.2677796372449344
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.005	0.2677796372449344
#615348 NEMALINE MYOPATHY 8; NEM8	0.005	0.2677796372449344
268650 RUDIGER SYNDROME	0.005	0.2677796372449344
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.005	0.2677796372449344
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.005	0.2677796372449344
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.005	0.2677796372449344
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.005	0.2677796372449344
#200700 CHONDRODYSPLASIA, GREBE TYPE;;ACHONDROGENESIS, BRAZILIAN;;GREBE CHONDRODYSPLASIA;;GREBE DYSPLASIA;;ACROMESOMELIC DYSPLASIA, GREBE TYPE; AMDG;;ACHONDROGENESIS, TYPE II, FORMERLY	0.005	0.2677796372449344
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.005	0.2677796372449344
RESTRICTIVE DERMOPATHY, LETHAL	0.005	0.2677796372449344
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.005	0.2677796372449344
#300717 MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE	0.005	0.2677796372449344
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.005	0.2677796372449344
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.005	0.2677796372449344
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.005	0.2677796372449344
HURLER SYNDROME	0.005	0.2677796372449344
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.005	0.2677796372449344
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.005	0.2677796372449344
#613205 MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED;;MDCL	0.005	0.2677796372449344
STIFF SKIN SYNDROME	0.005	0.2677796372449344
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.005	0.2677796372449344
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.005	0.2677796372449344
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.005	0.2677796372449344
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.005	0.2677796372449344
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.005	0.2677796372449344
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B	0.005	0.2677796372449344
#613869 MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED;;MFM, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	0.005	0.2677796372449344
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.005	0.2677796372449344
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.005	0.2677796372449344
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.005	0.2677796372449344
AASE-SMITH SYNDROME I	0.005	0.2677796372449344
NEMALINE MYOPATHY 1; NEM1	0.005	0.2677796372449344
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.005	0.2677796372449344
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.005	0.2677796372449344
#607706 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE;;CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A, AXONAL FORM;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE	0.005	0.2677796372449344
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.005	0.2677796372449344
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.005	0.2677796372449344
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.005	0.2677796372449344
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.005	0.2677796372449344
HYPERMANGANESEMIA WITH DYSTONIA 2	0.005	0.2677796372449344
#300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM;;SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	0.005	0.2677796372449344
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.005	0.2677796372449344
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.005	0.2677796372449344
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.005	0.2677796372449344
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.005	0.2677796372449344
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.005	0.2677796372449344
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.005	0.2677796372449344
BASAN SYNDROME	0.005	0.2677796372449344
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.004195271	0.22468162930483868
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.004195271	0.22468162930483868
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.004195271	0.22468162930483868
Glycosylphosphatidylinositol biosynthesis defect 18	0.004195271	0.22468162930483868
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.004195271	0.22468162930483868
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.004195271	0.22468162930483868
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.004195271	0.22468162930483868
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.004195271	0.22468162930483868
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004195271	0.22468162930483868
WITTEVEEN-KOLK SYNDROME	0.004195271	0.22468162930483868
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.004195271	0.22468162930483868
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.004195271	0.22468162930483868
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.004195271	0.22468162930483868
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004195271	0.22468162930483868
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004195271	0.22468162930483868
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.004195271	0.22468162930483868
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.004195271	0.22468162930483868
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.004195271	0.22468162930483868
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004195271	0.22468162930483868
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.004195271	0.22468162930483868
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004195271	0.22468162930483868
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.004195271	0.22468162930483868
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.004195271	0.22468162930483868
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004195271	0.22468162930483868
CHROMOSOME 18Q DELETION SYNDROME	0.004195271	0.22468162930483868
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.004195271	0.22468162930483868
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.004195271	0.22468162930483868
COFFIN-SIRIS SYNDROME 1; CSS1	0.004195271	0.22468162930483868
ADENYLOSUCCINASE DEFICIENCY	0.004195271	0.22468162930483868
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.004195271	0.22468162930483868
PELIZAEUS-MERZBACHER DISEASE	0.004195271	0.22468162930483868
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.004195271	0.22468162930483868
PETERS-PLUS SYNDROME; PTRPLS	0.004195271	0.22468162930483868
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.004195271	0.22468162930483868
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.004195271	0.22468162930483868
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.004195271	0.22468162930483868
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.004195271	0.22468162930483868
CHROMOSOME 19p13.13 DELETION SYNDROME	0.004195271	0.22468162930483868
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.004195271	0.22468162930483868
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004195271	0.22468162930483868
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.004195271	0.22468162930483868
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.004195271	0.22468162930483868
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.004195271	0.22468162930483868
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.004195271	0.22468162930483868
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004195271	0.22468162930483868
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.004195271	0.22468162930483868
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.00327952	0.17563773518750148
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00327952	0.17563773518750148
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00327952	0.17563773518750148
AICARDI-GOUTIERES SYNDROME 6	0.00327952	0.17563773518750148
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00327952	0.17563773518750148
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00327952	0.17563773518750148
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00327952	0.17563773518750148
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00327952	0.17563773518750148
FOCAL DERMAL HYPOPLASIA; FDH	0.00327952	0.17563773518750148
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00327952	0.17563773518750148
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.00327952	0.17563773518750148
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00327952	0.17563773518750148
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00327952	0.17563773518750148
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00327952	0.17563773518750148
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00327952	0.17563773518750148
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00327952	0.17563773518750148
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00327952	0.17563773518750148
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00327952	0.17563773518750148
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00327952	0.17563773518750148
MEVALONIC ACIDURIA; MEVA	0.00327952	0.17563773518750148
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00327952	0.17563773518750148
LEIGH SYNDROME; LS	0.002919761	0.1563705082843814
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.002919761	0.1563705082843814
ELEJALDE DISEASE	0.002919761	0.1563705082843814
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.002919761	0.1563705082843814
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002919761	0.1563705082843814
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.002919761	0.1563705082843814
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.002919761	0.1563705082843814
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.002919761	0.1563705082843814
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.002919761	0.1563705082843814
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.002919761	0.1563705082843814
OCULOCEREBROCUTANEOUS SYNDROME	0.002919761	0.1563705082843814
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002919761	0.1563705082843814
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.002919761	0.1563705082843814
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.002919761	0.1563705082843814
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.002919761	0.1563705082843814
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.002919761	0.1563705082843814
SCHINDLER DISEASE, TYPE I	0.002919761	0.1563705082843814
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.002919761	0.1563705082843814
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.002919761	0.1563705082843814
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.002919761	0.1563705082843814
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002919761	0.1563705082843814
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.002919761	0.1563705082843814
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.002919761	0.1563705082843814
NEURAMINIDASE DEFICIENCY	0.002919761	0.1563705082843814
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002919761	0.1563705082843814
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.002919761	0.1563705082843814
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.002919761	0.1563705082843814
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002919761	0.1563705082843814
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.002919761	0.1563705082843814
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.002919761	0.1563705082843814
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002919761	0.1563705082843814
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.002919761	0.1563705082843814
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002919761	0.1563705082843814
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002919761	0.1563705082843814
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.002919761	0.1563705082843814
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002919761	0.1563705082843814
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.002919761	0.1563705082843814
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002919761	0.1563705082843814
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.002919761	0.1563705082843814
PERRAULT SYNDROME 5; PRLTS5	0.002919761	0.1563705082843814
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.002919761	0.1563705082843814
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.002919761	0.1563705082843814
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.002919761	0.1563705082843814
GAPO SYNDROME; GAPOS	0.002919761	0.1563705082843814
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.002919761	0.1563705082843814
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.002919761	0.1563705082843814
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.002919761	0.1563705082843814
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.002919761	0.1563705082843814
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.002919761	0.1563705082843814
EPISODIC ATAXIA, TYPE 6	0.002919761	0.1563705082843814
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.002919761	0.1563705082843814
ACROCALLOSAL SYNDROME; ACLS	0.002919761	0.1563705082843814
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.002919761	0.1563705082843814
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.002919761	0.1563705082843814
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.002919761	0.1563705082843814
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.002919761	0.1563705082843814
INFANTILE SIALIC ACID STORAGE DISEASE	0.002919761	0.1563705082843814
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.002919761	0.1563705082843814
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002919761	0.1563705082843814
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.002919761	0.1563705082843814
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.002919761	0.1563705082843814
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.002919761	0.1563705082843814
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002919761	0.1563705082843814
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002919761	0.1563705082843814
KRABBE DISEASE	0.002919761	0.1563705082843814
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.002919761	0.1563705082843814
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.002919761	0.1563705082843814
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002919761	0.1563705082843814
Pontine tegmental cap dysplasia	0.002919761	0.1563705082843814
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.002919761	0.1563705082843814
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.002919761	0.1563705082843814
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.002919761	0.1563705082843814
OCULOECTODERMAL SYNDROME; OES	0.002919761	0.1563705082843814
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002919761	0.1563705082843814
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002919761	0.1563705082843814
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.002919761	0.1563705082843814
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.002919761	0.1563705082843814
ANGELMAN SYNDROME	0.002919761	0.1563705082843814
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.002919761	0.1563705082843814
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.002919761	0.1563705082843814
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.002919761	0.1563705082843814
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.002919761	0.1563705082843814
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.002919761	0.1563705082843814
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.002919761	0.1563705082843814
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.002919761	0.1563705082843814
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.002919761	0.1563705082843814
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.002919761	0.1563705082843814
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002919761	0.1563705082843814
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.002919761	0.1563705082843814
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.002919761	0.1563705082843814
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.002919761	0.1563705082843814
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002919761	0.1563705082843814
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.002919761	0.1563705082843814
SALLA DISEASE	0.002919761	0.1563705082843814
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.002919761	0.1563705082843814
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002919761	0.1563705082843814
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.002919761	0.1563705082843814
BARAITSER-WINTER SYNDROME 1; BRWS1	0.002191261	0.11735501513779445
Angelman syndrome (Type 1)	0.002191261	0.11735501513779445
SUPRABULBAR PARESIS, CONGENITAL	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.002191261	0.11735501513779445
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002191261	0.11735501513779445
PSEUDO-TORCH SYNDROME 2	0.002191261	0.11735501513779445
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.002191261	0.11735501513779445
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.002191261	0.11735501513779445
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.002191261	0.11735501513779445
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.002191261	0.11735501513779445
INCONTINENTIA PIGMENTI; IP	0.002191261	0.11735501513779445
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.002191261	0.11735501513779445
KOOLEN-DE VRIES SYNDROME; KDVS	0.002191261	0.11735501513779445
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002191261	0.11735501513779445
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.002191261	0.11735501513779445
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.002191261	0.11735501513779445
MOWAT-WILSON SYNDROME; MOWS	0.002191261	0.11735501513779445
AICARDI-GOUTIERES SYNDROME 7	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.002191261	0.11735501513779445
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.002191261	0.11735501513779445
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002191261	0.11735501513779445
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.002191261	0.11735501513779445
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.002191261	0.11735501513779445
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.002191261	0.11735501513779445
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002191261	0.11735501513779445
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002191261	0.11735501513779445
POTOCKI-LUPSKI SYNDROME	0.002191261	0.11735501513779445
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.002191261	0.11735501513779445
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002191261	0.11735501513779445
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.002191261	0.11735501513779445
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.002191261	0.11735501513779445
N-ACETYLASPARTATE DEFICIENCY; NACED	0.002191261	0.11735501513779445
SECKEL SYNDROME 7; SCKL7	0.002191261	0.11735501513779445
HOLOPROSENCEPHALY 1; HPE1	0.002191261	0.11735501513779445
HOLOPROSENCEPHALY 2; HPE2	0.002191261	0.11735501513779445
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.002191261	0.11735501513779445
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.002191261	0.11735501513779445
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002191261	0.11735501513779445
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002191261	0.11735501513779445
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.002191261	0.11735501513779445
AL KAISSI SYNDROME; ALKAS	0.002191261	0.11735501513779445
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.002191261	0.11735501513779445
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.002191261	0.11735501513779445
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.002191261	0.11735501513779445
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.002191261	0.11735501513779445
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.002191261	0.11735501513779445
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.002191261	0.11735501513779445
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002191261	0.11735501513779445
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002191261	0.11735501513779445
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.002191261	0.11735501513779445
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.002191261	0.11735501513779445
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002191261	0.11735501513779445
CHROMOSOME 1p35 DELETION SYNDROME	0.002191261	0.11735501513779445
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.002191261	0.11735501513779445
MEHMO SYNDROME; MEHMO	0.002191261	0.11735501513779445
COFFIN-SIRIS SYNDROME 4; CSS4	0.002191261	0.11735501513779445
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.002191261	0.11735501513779445
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.002191261	0.11735501513779445
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.002191261	0.11735501513779445
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002191261	0.11735501513779445
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002191261	0.11735501513779445
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.002191261	0.11735501513779445
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.002191261	0.11735501513779445
Xq28 (MECP2) duplication	0.002191261	0.11735501513779445
CYCLIC VOMITING SYNDROME	0.002191261	0.11735501513779445
CHROMOSOME 16p13.3 DELETION SYNDROME	0.002191261	0.11735501513779445
COFFIN-SIRIS SYNDROME 3; CSS3	0.002191261	0.11735501513779445
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.002191261	0.11735501513779445
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002191261	0.11735501513779445
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.002191261	0.11735501513779445
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.002191261	0.11735501513779445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002191261	0.11735501513779445
KLEEFSTRA SYNDROME	0.002191261	0.11735501513779445
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.002191261	0.11735501513779445
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.002191261	0.11735501513779445
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.002191261	0.11735501513779445
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.002191261	0.11735501513779445
KLEEFSTRA SYNDROME 2; KLEFS2	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.002191261	0.11735501513779445
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.002191261	0.11735501513779445
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.002191261	0.11735501513779445
INFANTILE LIVER FAILURE SYNDROME 1	0.002191261	0.11735501513779445
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.002191261	0.11735501513779445
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.002191261	0.11735501513779445
#300867 KABUKI SYNDROME 2; KABUK2	0.002191261	0.11735501513779445
LISSENCEPHALY 8; LIS8	0.002191261	0.11735501513779445
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.002191261	0.11735501513779445
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.002191261	0.11735501513779445
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.002191261	0.11735501513779445
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002191261	0.11735501513779445
CHROMOSOME 10Q26 DELETION SYNDROME	0.002191261	0.11735501513779445
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.002191261	0.11735501513779445
COFFIN-LOWRY SYNDROME; CLS	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.002191261	0.11735501513779445
Wolf-Hirschhorn Syndrome	0.002191261	0.11735501513779445
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.002191261	0.11735501513779445
PERRAULT SYNDROME 3	0.002191261	0.11735501513779445
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.002191261	0.11735501513779445
LISSENCEPHALY 3; LIS3	0.002191261	0.11735501513779445
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.002191261	0.11735501513779445
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.002191261	0.11735501513779445
XYLOSIDASE DEFICIENCY	0.002191261	0.11735501513779445
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.002191261	0.11735501513779445
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.002191261	0.11735501513779445
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002191261	0.11735501513779445
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002191261	0.11735501513779445
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002191261	0.11735501513779445
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.002191261	0.11735501513779445
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.002191261	0.11735501513779445
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.002191261	0.11735501513779445
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.002191261	0.11735501513779445
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.002191261	0.11735501513779445
KBG SYNDROME	0.002191261	0.11735501513779445
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.002191261	0.11735501513779445
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002191261	0.11735501513779445
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.002191261	0.11735501513779445
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.002191261	0.11735501513779445
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002191261	0.11735501513779445
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002191261	0.11735501513779445
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.002191261	0.11735501513779445
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.002191261	0.11735501513779445
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.002191261	0.11735501513779445
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.002191261	0.11735501513779445
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002191261	0.11735501513779445
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.002191261	0.11735501513779445
Angelman syndrome (Type 2)	0.002191261	0.11735501513779445
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.002191261	0.11735501513779445
PHENYLKETONURIA	0.002191261	0.11735501513779445
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.002191261	0.11735501513779445
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.002191261	0.11735501513779445
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.002191261	0.11735501513779445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.002191261	0.11735501513779445
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.002191261	0.11735501513779445
COFFIN-SIRIS SYNDROME 5	0.002191261	0.11735501513779445
MENTAL RETARDATION, X-LINKED 102	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.002191261	0.11735501513779445
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.002191261	0.11735501513779445
KABUKI SYNDROME 1	0.002191261	0.11735501513779445
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.002191261	0.11735501513779445
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.002191261	0.11735501513779445
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.002191261	0.11735501513779445
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.002191261	0.11735501513779445
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.002191261	0.11735501513779445
PITT-HOPKINS SYNDROME	0.002191261	0.11735501513779445
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.002191261	0.11735501513779445
KEARNS-SAYRE SYNDROME; KSS	0.002191261	0.11735501513779445
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.002191261	0.11735501513779445
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002191261	0.11735501513779445
JABERI-ELAHI SYNDROME; JABELS	0.002191261	0.11735501513779445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002191261	0.11735501513779445
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.002191261	0.11735501513779445
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.002191261	0.11735501513779445
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.002191261	0.11735501513779445
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002191261	0.11735501513779445
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.002191261	0.11735501513779445
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.002191261	0.11735501513779445
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002191261	0.11735501513779445
Pierpont syndrome	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.002191261	0.11735501513779445
EMANUEL SYNDROME	0.002191261	0.11735501513779445
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.002191261	0.11735501513779445
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.002191261	0.11735501513779445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.002191261	0.11735501513779445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002191261	0.11735501513779445
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.002191261	0.11735501513779445
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.002191261	0.11735501513779445
LISSENCEPHALY 4	0.002191261	0.11735501513779445
C SYNDROME	0.002191261	0.11735501513779445
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.002191261	0.11735501513779445
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002191261	0.11735501513779445
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.002191261	0.11735501513779445
ASPARTYLGLUCOSAMINURIA; AGU	0.002191261	0.11735501513779445
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.002191261	0.11735501513779445
COHEN SYNDROME	0.002191261	0.11735501513779445
FILIPPI SYNDROME; FLPIS	0.002191261	0.11735501513779445
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002191261	0.11735501513779445
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.002191261	0.11735501513779445
PHELAN-MCDERMID SYNDROME; PHMDS	0.002191261	0.11735501513779445
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002191261	0.11735501513779445
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.002191261	0.11735501513779445
LATHOSTEROLOSIS	0.002191261	0.11735501513779445
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002191261	0.11735501513779445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.002191261	0.11735501513779445
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.002191261	0.11735501513779445
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 18	0.00200401	0.10732661416704421
#614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;NPHS5	0.00200401	0.10732661416704421
CHIARI MALFORMATION TYPE II	0.00200401	0.10732661416704421
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00200401	0.10732661416704421
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00200401	0.10732661416704421
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.00200401	0.10732661416704421
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00200401	0.10732661416704421
CONE-ROD DYSTROPHY 20; CORD20	0.00200401	0.10732661416704421
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00200401	0.10732661416704421
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00200401	0.10732661416704421
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00200401	0.10732661416704421
REVESZ SYNDROME	0.00200401	0.10732661416704421
FOVEAL HYPOPLASIA 2; FVH2	0.00200401	0.10732661416704421
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.00200401	0.10732661416704421
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00200401	0.10732661416704421
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.00200401	0.10732661416704421
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00200401	0.10732661416704421
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00200401	0.10732661416704421
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.00200401	0.10732661416704421
NEPHRONOPHTHISIS 11; NPHP11	0.00200401	0.10732661416704421
ANIRIDIA	0.00200401	0.10732661416704421
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.00200401	0.10732661416704421
#610024 RETINAL CONE DYSTROPHY 3A; RCD3A;;CONE DYSTROPHY WITH NIGHT BLINDNESS AND SUPERNORMAL ROD RESPONSES,PDE6H-RELATEDACHROMATOPSIA 6, INCLUDED; ACHM6, INCLUDED	0.00200401	0.10732661416704421
NYSTAGMUS, VOLUNTARY	0.00200401	0.10732661416704421
#614076 HERMANSKY-PUDLAK SYNDROME 7; HPS7	0.00200401	0.10732661416704421
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00200401	0.10732661416704421
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00200401	0.10732661416704421
LENTIGINES	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00200401	0.10732661416704421
RICHARDS-RUNDLE SYNDROME; RRNS	0.00200401	0.10732661416704421
REFSUM DISEASE	0.00200401	0.10732661416704421
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00200401	0.10732661416704421
#604232 LEBER CONGENITAL AMAUROSIS 3; LCA3RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED, INCLUDED	0.00200401	0.10732661416704421
JOUBERT SYNDROME 32; JBTS32	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 14	0.00200401	0.10732661416704421
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00200401	0.10732661416704421
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.00200401	0.10732661416704421
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00200401	0.10732661416704421
EXUDATIVE VITREORETINOPATHY 7; EVR7	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 1	0.00200401	0.10732661416704421
PEROXISOME BIOGENESIS DISORDER 5B	0.00200401	0.10732661416704421
BAKER-GORDON SYNDROME; BAGOS	0.00200401	0.10732661416704421
JOUBERT SYNDROME 27	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00200401	0.10732661416704421
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.00200401	0.10732661416704421
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00200401	0.10732661416704421
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00200401	0.10732661416704421
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00200401	0.10732661416704421
TERATOMA, PINEAL	0.00200401	0.10732661416704421
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00200401	0.10732661416704421
SPONDYLOOCULAR SYNDROME; SOS	0.00200401	0.10732661416704421
CRANIOECTODERMAL DYSPLASIA 1	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00200401	0.10732661416704421
CEREBELLAR HYPOPLASIA	0.00200401	0.10732661416704421
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.00200401	0.10732661416704421
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00200401	0.10732661416704421
JOUBERT SYNDROME 31; JBTS31	0.00200401	0.10732661416704421
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00200401	0.10732661416704421
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00200401	0.10732661416704421
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00200401	0.10732661416704421
LEBER CONGENITAL AMAUROSIS 16	0.00200401	0.10732661416704421
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00200401	0.10732661416704421
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00200401	0.10732661416704421
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00200401	0.10732661416704421
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00200401	0.10732661416704421
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00200401	0.10732661416704421
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00200401	0.10732661416704421
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00200401	0.10732661416704421
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00200401	0.10732661416704421
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00200401	0.10732661416704421
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00200401	0.10732661416704421
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00200401	0.10732661416704421
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00200401	0.10732661416704421
JOUBERT SYNDROME 26	0.00200401	0.10732661416704421
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00200401	0.10732661416704421
PETERS ANOMALY	0.00200401	0.10732661416704421
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00200401	0.10732661416704421
Pelizaeus-Merzbacher disease	0.00200401	0.10732661416704421
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00200401	0.10732661416704421
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00200401	0.10732661416704421
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00200401	0.10732661416704421
WAARDENBURG-SHAH SYNDROME	0.00200401	0.10732661416704421
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.00200401	0.10732661416704421
SENIOR-LOKEN SYNDROME 9	0.00200401	0.10732661416704421
GILLESPIE SYNDROME; GLSP	0.00200401	0.10732661416704421
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00200401	0.10732661416704421
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.00200401	0.10732661416704421
EPISODIC ATAXIA, TYPE 8	0.00200401	0.10732661416704421
#604432 SPINOCEREBELLAR ATAXIA 11; SCA11	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00200401	0.10732661416704421
JOUBERT SYNDROME 3; JBTS3	0.00200401	0.10732661416704421
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.00200401	0.10732661416704421
JOUBERT SYNDROME 24	0.00200401	0.10732661416704421
CONE-ROD DYSTROPHY 6; CORD6	0.00200401	0.10732661416704421
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00200401	0.10732661416704421
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00200401	0.10732661416704421
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00200401	0.10732661416704421
NAVAJO NEUROHEPATOPATHY	0.00200401	0.10732661416704421
ACHROMATOPSIA 7; ACHM7	0.00200401	0.10732661416704421
JOUBERT SYNDROME 28	0.00200401	0.10732661416704421
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 26	0.00200401	0.10732661416704421
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.00200401	0.10732661416704421
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00200401	0.10732661416704421
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00200401	0.10732661416704421
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.00200401	0.10732661416704421
JOUBERT SYNDROME 7	0.00200401	0.10732661416704421
SENIOR-LOKEN SYNDROME 3	0.00200401	0.10732661416704421
NYSTAGMUS, MYOCLONIC	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00200401	0.10732661416704421
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00200401	0.10732661416704421
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00200401	0.10732661416704421
#613341 LEBER CONGENITAL AMAUROSIS 14; LCA14RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	0.00200401	0.10732661416704421
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00200401	0.10732661416704421
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.00200401	0.10732661416704421
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00200401	0.10732661416704421
CONE DYSTROPHY 4	0.00200401	0.10732661416704421
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00200401	0.10732661416704421
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00200401	0.10732661416704421
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00200401	0.10732661416704421
#305390 EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2;;EVRX;;FEVR, X-LINKED; FEVRX	0.00200401	0.10732661416704421
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00200401	0.10732661416704421
RETINITIS PIGMENTOSA 20	0.00200401	0.10732661416704421
#612109 OCULOAURICULAR SYNDROME; OCACS;;MICROPHTHALMIA, MICROCORNEA, ANTERIOR SEGMENT DYSGENESIS, CATARACT,OCULAR COLOBOMA, RETINAL PIGMENT EPITHELIUM ABNORMALITIES, ROD-CONEDYSTROPHY, AND ANOMALIES OF THE EXTERNAL EAR;;SCHORDERET-MUNIER-FRANCESCHETTI SYNDROME	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00200401	0.10732661416704421
#613856 ACHROMATOPSIA 4; ACHM4	0.00200401	0.10732661416704421
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00200401	0.10732661416704421
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00200401	0.10732661416704421
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00200401	0.10732661416704421
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 13	0.00200401	0.10732661416704421
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00200401	0.10732661416704421
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00200401	0.10732661416704421
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00200401	0.10732661416704421
JOUBERT SYNDROME 5	0.00200401	0.10732661416704421
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00200401	0.10732661416704421
Oliver-McFarlane syndrome	0.00200401	0.10732661416704421
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00200401	0.10732661416704421
#608553 LEBER CONGENITAL AMAUROSIS 9; LCA9	0.00200401	0.10732661416704421
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.00200401	0.10732661416704421
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00200401	0.10732661416704421
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00200401	0.10732661416704421
JOUBERT SYNDROME 2	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00200401	0.10732661416704421
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.00200401	0.10732661416704421
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.00200401	0.10732661416704421
BLUE CONE MONOCHROMACY; BCM	0.00200401	0.10732661416704421
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00200401	0.10732661416704421
VITREORETINOCHOROIDOPATHY; VRCP	0.00200401	0.10732661416704421
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00200401	0.10732661416704421
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00200401	0.10732661416704421
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00200401	0.10732661416704421
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00200401	0.10732661416704421
245800 LAURENCE-MOON SYNDROME	0.00200401	0.10732661416704421
#216900 ACHROMATOPSIA 2; ACHM2;;COLORBLINDNESS, TOTAL;;ROD MONOCHROMATISM 2;;ROD MONOCHROMACY 2; RMCH2	0.00200401	0.10732661416704421
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00200401	0.10732661416704421
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00200401	0.10732661416704421
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00200401	0.10732661416704421
CHIARI MALFORMATION TYPE I	0.00200401	0.10732661416704421
PEROXISOME BIOGENESIS DISORDER 10B	0.00200401	0.10732661416704421
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.00200401	0.10732661416704421
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00200401	0.10732661416704421
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00200401	0.10732661416704421
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00200401	0.10732661416704421
SOTOS SYNDROME 2	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00200401	0.10732661416704421
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00200401	0.10732661416704421
PEROXISOME BIOGENESIS DISORDER 6B	0.00200401	0.10732661416704421
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00200401	0.10732661416704421
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00200401	0.10732661416704421
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00200401	0.10732661416704421
#217080 JALILI SYNDROME;;CONE-ROD DYSTROPHY AND AMELOGENESIS IMPERFECTA	0.00200401	0.10732661416704421
RETINITIS PIGMENTOSA 14	0.00200401	0.10732661416704421
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00200401	0.10732661416704421
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00200401	0.10732661416704421
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00200401	0.10732661416704421
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 20	0.00200401	0.10732661416704421
CHANARIN-DORFMAN SYNDROME	0.00200401	0.10732661416704421
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.00200401	0.10732661416704421
#606952 ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B;;OCULOCUTANEOUS ALBINISM, TYPE IB;;ALBINISM, YELLOW MUTANT TYPE;;YELLOW ALBINISMALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;;OCA1-TS, INCLUDED	0.00200401	0.10732661416704421
#276880 UROCANASE DEFICIENCY	0.00200401	0.10732661416704421
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00200401	0.10732661416704421
CRANIOFRONTONASAL SYNDROME; CFNS	0.00200401	0.10732661416704421
JOUBERT SYNDROME 4	0.00200401	0.10732661416704421
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00200401	0.10732661416704421
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.00200401	0.10732661416704421
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00200401	0.10732661416704421
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00200401	0.10732661416704421
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00200401	0.10732661416704421
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00200401	0.10732661416704421
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00200401	0.10732661416704421
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00200401	0.10732661416704421
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00200401	0.10732661416704421
COLOBOMA, OCULAR	0.00200401	0.10732661416704421
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00200401	0.10732661416704421
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.00200401	0.10732661416704421
MYELOCEREBELLAR DISORDER	0.00200401	0.10732661416704421
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00200401	0.10732661416704421
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00200401	0.10732661416704421
ALAND ISLAND EYE DISEASE	0.00200401	0.10732661416704421
#606574 ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV	0.00200401	0.10732661416704421
OROFACIODIGITAL SYNDROME VI	0.00200401	0.10732661416704421
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00200401	0.10732661416704421
SYRINGOMYELIA, ISOLATED	0.00200401	0.10732661416704421
DANDY-WALKER SYNDROME	0.00200401	0.10732661416704421
SCLEROSTEOSIS 1; SOST1	0.00200401	0.10732661416704421
#615179 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00200401	0.10732661416704421
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.00200401	0.10732661416704421
ARIMA SYNDROME	0.00200401	0.10732661416704421
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00200401	0.10732661416704421
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.00200401	0.10732661416704421
RETINITIS PIGMENTOSA 12; RP12	0.00200401	0.10732661416704421
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00127551	0.06831112102045726
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.00127551	0.06831112102045726
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00127551	0.06831112102045726
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.00127551	0.06831112102045726
#614728 SECKEL SYNDROME 6; SCKL6	0.00127551	0.06831112102045726
MICROCEPHALY-CARDIOMYOPATHY	0.00127551	0.06831112102045726
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00127551	0.06831112102045726
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.06831112102045726
SECKEL SYNDROME 2; SCKL2	0.00127551	0.06831112102045726
OCULOPALATOCEREBRAL SYNDROME	0.00127551	0.06831112102045726
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00127551	0.06831112102045726
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00127551	0.06831112102045726
#615328 SHAHEEN SYNDROME; SHNS	0.00127551	0.06831112102045726
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00127551	0.06831112102045726
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00127551	0.06831112102045726
CRI-DU-CHAT SYNDROME	0.00127551	0.06831112102045726
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.00127551	0.06831112102045726
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.06831112102045726
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00127551	0.06831112102045726
SECKEL SYNDROME 5; SCKL5	0.00127551	0.06831112102045726
FANCONI ANEMIA	0.00127551	0.06831112102045726
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00127551	0.06831112102045726
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00127551	0.06831112102045726
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00127551	0.06831112102045726
NEU-LAXOVA SYNDROME 2; NLS2	0.00127551	0.06831112102045726
MASA SYNDROME	0.00127551	0.06831112102045726
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00127551	0.06831112102045726
PSEUDOTRISOMY 13 SYNDROME	0.00127551	0.06831112102045726
HYPERREFLEXIA	0.00127551	0.06831112102045726
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00127551	0.06831112102045726
SECKEL SYNDROME 8; SCKL8	0.00127551	0.06831112102045726
MENTAL RETARDATION, X-LINKED 63	0.00127551	0.06831112102045726
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00127551	0.06831112102045726
OPTIC ATROPHY 11; OPA11	0.00127551	0.06831112102045726
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00127551	0.06831112102045726
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00127551	0.06831112102045726
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.00127551	0.06831112102045726
9q subtelomeric deletion syndrome	0.00127551	0.06831112102045726
TOWNES-BROCKS SYNDROME 1; TBS1	0.00127551	0.06831112102045726
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00127551	0.06831112102045726
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00127551	0.06831112102045726
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00127551	0.06831112102045726
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00127551	0.06831112102045726
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.00127551	0.06831112102045726
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00127551	0.06831112102045726
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00127551	0.06831112102045726
LOWRY-MACLEAN SYNDROME	0.00127551	0.06831112102045726
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00127551	0.06831112102045726
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.00127551	0.06831112102045726
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00127551	0.06831112102045726
JOHANSON-BLIZZARD SYNDROME; JBS	0.00127551	0.06831112102045726
MECKEL SYNDROME, TYPE 1; MKS1	0.00127551	0.06831112102045726
DE SANCTIS-CACCHIONE SYNDROME	0.00127551	0.06831112102045726
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.06831112102045726
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00127551	0.06831112102045726
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.06831112102045726
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.06831112102045726
TURNPENNY-FRY SYNDROME; TPFS	0.00127551	0.06831112102045726
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00127551	0.06831112102045726
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.00127551	0.06831112102045726
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.06831112102045726
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00127551	0.06831112102045726
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.06831112102045726
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00127551	0.06831112102045726
FORSYTHE-WAKELING SYNDROME; FWS	0.00127551	0.06831112102045726
LIG4 SYNDROME	0.00127551	0.06831112102045726
HADZISELIMOVIC SYNDROME	0.00127551	0.06831112102045726
HOLOPROSENCEPHALY 5; HPE5	0.00127551	0.06831112102045726
FACIOCARDIOMELIC SYNDROME	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00127551	0.06831112102045726
SECKEL SYNDROME 9; SCKL9	0.00127551	0.06831112102045726
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00127551	0.06831112102045726
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00127551	0.06831112102045726
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00127551	0.06831112102045726
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00127551	0.06831112102045726
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00127551	0.06831112102045726
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00127551	0.06831112102045726
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00127551	0.06831112102045726
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00127551	0.06831112102045726
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00127551	0.06831112102045726
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00127551	0.06831112102045726
3MC SYNDROME 1	0.00127551	0.06831112102045726
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00127551	0.06831112102045726
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.06831112102045726
BLOOM SYNDROME	0.00127551	0.06831112102045726
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.06831112102045726
SECKEL SYNDROME 4	0.00127551	0.06831112102045726
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00127551	0.06831112102045726
ENCEPHALOMALACIA, MULTILOCULAR	0.00127551	0.06831112102045726
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00127551	0.06831112102045726
CRANIOSYNOSTOSIS 6; CRS6	0.00127551	0.06831112102045726
MICROPHTHALMIA, SYNDROMIC 3	0.00127551	0.06831112102045726
COFFIN-SIRIS SYNDROME 10; CSS10	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00127551	0.06831112102045726
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00127551	0.06831112102045726
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00127551	0.06831112102045726
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.00127551	0.06831112102045726
WARSAW BREAKAGE SYNDROME; WABS	0.00127551	0.06831112102045726
MEIER-GORLIN SYNDROME 5; MGORS5	0.00127551	0.06831112102045726
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.06831112102045726
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00127551	0.06831112102045726
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00127551	0.06831112102045726
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00127551	0.06831112102045726
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00127551	0.06831112102045726
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00127551	0.06831112102045726
AL-RAQAD SYNDROME; ARS	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00127551	0.06831112102045726
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00127551	0.06831112102045726
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00127551	0.06831112102045726
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00127551	0.06831112102045726
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00127551	0.06831112102045726
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00127551	0.06831112102045726
CARDIAC LIPIDOSIS, FAMILIAL	0.00127551	0.06831112102045726
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00127551	0.06831112102045726
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.06831112102045726
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.06831112102045726
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00127551	0.06831112102045726
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00127551	0.06831112102045726
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00127551	0.06831112102045726
FONTAINE PROGEROID SYNDROME; FPS	0.00127551	0.06831112102045726
Leukotriene C4 synthase deficiency	0.00127551	0.06831112102045726
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00127551	0.06831112102045726
HOLOPROSENCEPHALY 11	0.00127551	0.06831112102045726
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00127551	0.06831112102045726
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00127551	0.06831112102045726
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00127551	0.06831112102045726
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00127551	0.06831112102045726
BARDET-BIEDL SYNDROME 20	0.00127551	0.06831112102045726
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00127551	0.06831112102045726
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00127551	0.06831112102045726
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.06831112102045726
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00127551	0.06831112102045726
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.06831112102045726
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00127551	0.06831112102045726
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00127551	0.06831112102045726
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00127551	0.06831112102045726
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00127551	0.06831112102045726
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00127551	0.06831112102045726
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.00127551	0.06831112102045726
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00127551	0.06831112102045726
BARATELA-SCOTT SYNDROME	0.00127551	0.06831112102045726
LAMBOTTE SYNDROME	0.00127551	0.06831112102045726
ACHALASIA-MICROCEPHALY SYNDROME	0.00127551	0.06831112102045726
Diamond-Blackfan anemia 1	0.00127551	0.06831112102045726
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00127551	0.06831112102045726
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.06831112102045726
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00127551	0.06831112102045726
MARTSOLF SYNDROME	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00127551	0.06831112102045726
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00127551	0.06831112102045726
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00127551	0.06831112102045726
Miller-Dieker syndrome (MDS)	0.00127551	0.06831112102045726
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00127551	0.06831112102045726
CEREBELLOFACIODENTAL SYNDROME	0.00127551	0.06831112102045726
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00127551	0.06831112102045726
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00127551	0.06831112102045726
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00127551	0.06831112102045726
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00127551	0.06831112102045726
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00127551	0.06831112102045726
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00127551	0.06831112102045726
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00127551	0.06831112102045726
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00127551	0.06831112102045726
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.00127551	0.06831112102045726
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00127551	0.06831112102045726
SAY SYNDROME	0.00127551	0.06831112102045726
HOLOPROSENCEPHALY 3; HPE3	0.00127551	0.06831112102045726
BOWEN-CONRADI SYNDROME	0.00127551	0.06831112102045726
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00127551	0.06831112102045726
NIJMEGEN BREAKAGE SYNDROME	0.00127551	0.06831112102045726
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00127551	0.06831112102045726
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00127551	0.06831112102045726
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00127551	0.06831112102045726
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00127551	0.06831112102045726
ADAMS-OLIVER SYNDROME 3; AOS3	0.00127551	0.06831112102045726
STROMME SYNDROME; STROMS	0.00127551	0.06831112102045726
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.06831112102045726
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00127551	0.06831112102045726
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00127551	0.06831112102045726
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00127551	0.06831112102045726
RUVALCABA SYNDROME	0.00127551	0.06831112102045726
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00127551	0.06831112102045726
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00127551	0.06831112102045726
CHARGE SYNDROME	0.00127551	0.06831112102045726
YUNIS-VARON SYNDROME	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.00127551	0.06831112102045726
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00127551	0.06831112102045726
ALAZAMI SYNDROME; ALAZS	0.00127551	0.06831112102045726
IMMUNODEFICIENCY 55; IMD55	0.00127551	0.06831112102045726
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00127551	0.06831112102045726
FRONTONASAL DYSPLASIA 2; FND2	0.00127551	0.06831112102045726
#278250 WRINKLY SKIN SYNDROME; WSS	0.00127551	0.06831112102045726
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00127551	0.06831112102045726
HARTSFIELD SYNDROME; HRTFDS	0.00127551	0.06831112102045726
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.00127551	0.06831112102045726
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00127551	0.06831112102045726
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00127551	0.06831112102045726
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.06831112102045726
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.06831112102045726
VERVERI-BRADY SYNDROME; VERBRAS	0.00127551	0.06831112102045726
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00127551	0.06831112102045726
MEIER-GORLIN SYNDROME 6; MGORS6	0.00127551	0.06831112102045726
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00127551	0.06831112102045726
RHIZOMELIC SYNDROME	0.00127551	0.06831112102045726
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00127551	0.06831112102045726
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.00127551	0.06831112102045726
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00127551	0.06831112102045726
Cri du Chat Syndrome (5p deletion)	0.00127551	0.06831112102045726
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00127551	0.06831112102045726
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00127551	0.06831112102045726
FEINGOLD SYNDROME 1; FGLDS1	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00127551	0.06831112102045726
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00127551	0.06831112102045726
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00127551	0.06831112102045726
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00127551	0.06831112102045726
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00127551	0.06831112102045726
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00127551	0.06831112102045726
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00127551	0.06831112102045726
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00127551	0.06831112102045726
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00127551	0.06831112102045726
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00127551	0.06831112102045726
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.00127551	0.06831112102045726
MECKEL SYNDROME, TYPE 4; MKS4	0.00127551	0.06831112102045726
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00127551	0.06831112102045726
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00127551	0.06831112102045726
ALAZAMI-YUAN SYNDROME	0.00127551	0.06831112102045726
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00127551	0.06831112102045726
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00127551	0.06831112102045726
FEINGOLD SYNDROME 2; FGLDS2	0.00127551	0.06831112102045726
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00127551	0.06831112102045726
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00127551	0.06831112102045726
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00127551	0.06831112102045726
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.00127551	0.06831112102045726
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00127551	0.06831112102045726
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.00127551	0.06831112102045726
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00127551	0.06831112102045726
DUBOWITZ SYNDROME	0.00127551	0.06831112102045726
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00127551	0.06831112102045726
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00127551	0.06831112102045726
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00127551	0.06831112102045726
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.06831112102045726
VELOCARDIOFACIAL SYNDROME	0.00127551	0.06831112102045726
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00127551	0.06831112102045726
Mental retardation, autosomal dominant 21	0.00127551	0.06831112102045726
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00127551	0.06831112102045726
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00127551	0.06831112102045726
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00127551	0.06831112102045726
DYSTONIA 28, CHILDHOOD-ONSET	0.00127551	0.06831112102045726
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00127551	0.06831112102045726
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.00127551	0.06831112102045726
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.00127551	0.06831112102045726
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.06831112102045726
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00127551	0.06831112102045726
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.06831112102045726
OGDEN SYNDROME; OGDNS	0.00127551	0.06831112102045726
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00127551	0.06831112102045726
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00127551	0.06831112102045726
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00127551	0.06831112102045726
GOLDBERG-SHPRINTZEN SYNDROME	0.00127551	0.06831112102045726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00127551	0.06831112102045726
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00127551	0.06831112102045726
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00127551	0.06831112102045726
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00127551	0.06831112102045726
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00127551	0.06831112102045726
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.06831112102045726
MUCOLIPIDOSIS IV; ML4	0.00127551	0.06831112102045726
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00127551	0.06831112102045726
LARYNGEAL ABDUCTOR PARALYSIS	0.00127551	0.06831112102045726
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00127551	0.06831112102045726
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00127551	0.06831112102045726
MEIER-GORLIN SYNDROME 3; MGORS3	0.00127551	0.06831112102045726
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00127551	0.06831112102045726
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.04904389411733719
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.04904389411733719
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.04904389411733719
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000915751	0.04904389411733719
COWDEN SYNDROME 6; CWS6	0.000915751	0.04904389411733719
DYSOSTEOSCLEROSIS	0.000915751	0.04904389411733719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000915751	0.04904389411733719
PARIETAL FORAMINA	0.000915751	0.04904389411733719
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.000915751	0.04904389411733719
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000915751	0.04904389411733719
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000915751	0.04904389411733719
GLYCEROL KINASE DEFICIENCY; GKD	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000915751	0.04904389411733719
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000915751	0.04904389411733719
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.04904389411733719
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.04904389411733719
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000915751	0.04904389411733719
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 90	0.000915751	0.04904389411733719
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.04904389411733719
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000915751	0.04904389411733719
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.000915751	0.04904389411733719
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000915751	0.04904389411733719
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.04904389411733719
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000915751	0.04904389411733719
CLARK-BARAITSER SYNDROME	0.000915751	0.04904389411733719
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.04904389411733719
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.04904389411733719
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.04904389411733719
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000915751	0.04904389411733719
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.04904389411733719
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000915751	0.04904389411733719
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.04904389411733719
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.04904389411733719
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000915751	0.04904389411733719
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000915751	0.04904389411733719
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.04904389411733719
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.04904389411733719
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000915751	0.04904389411733719
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.04904389411733719
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000915751	0.04904389411733719
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000915751	0.04904389411733719
THYROCEREBRORETINAL SYNDROME	0.000915751	0.04904389411733719
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.04904389411733719
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.04904389411733719
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.04904389411733719
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000915751	0.04904389411733719
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.04904389411733719
TAY-SACHS DISEASE; TSD	0.000915751	0.04904389411733719
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 9	0.000915751	0.04904389411733719
CHROMOSOME 16p13.2 DELETION SYNDROME	0.000915751	0.04904389411733719
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000915751	0.04904389411733719
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000915751	0.04904389411733719
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000915751	0.04904389411733719
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000915751	0.04904389411733719
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.04904389411733719
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.04904389411733719
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000915751	0.04904389411733719
HYPERPROLINEMIA, TYPE II	0.000915751	0.04904389411733719
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.04904389411733719
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000915751	0.04904389411733719
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.04904389411733719
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.04904389411733719
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000915751	0.04904389411733719
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000915751	0.04904389411733719
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000915751	0.04904389411733719
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.04904389411733719
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.04904389411733719
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000915751	0.04904389411733719
ALZHEIMER DISEASE 3; AD	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000915751	0.04904389411733719
FOUNTAIN SYNDROME	0.000915751	0.04904389411733719
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.04904389411733719
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.04904389411733719
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.04904389411733719
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.04904389411733719
JOUBERT SYNDROME 30; JBTS30	0.000915751	0.04904389411733719
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.000915751	0.04904389411733719
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.04904389411733719
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.04904389411733719
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.04904389411733719
MIRAGE SYNDROME; MIRAGE	0.000915751	0.04904389411733719
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.04904389411733719
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000915751	0.04904389411733719
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.04904389411733719
ALEXANDER DISEASE	0.000915751	0.04904389411733719
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.000915751	0.04904389411733719
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000915751	0.04904389411733719
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.04904389411733719
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000915751	0.04904389411733719
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000915751	0.04904389411733719
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000915751	0.04904389411733719
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.04904389411733719
METACHROMATIC LEUKODYSTROPHY	0.000915751	0.04904389411733719
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.04904389411733719
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 72	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.04904389411733719
SULFOCYSTEINURIA	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000915751	0.04904389411733719
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 88	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.04904389411733719
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.04904389411733719
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.04904389411733719
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000915751	0.04904389411733719
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000915751	0.04904389411733719
KIFAFA SEIZURE DISORDER	0.000915751	0.04904389411733719
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.04904389411733719
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000915751	0.04904389411733719
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.04904389411733719
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000915751	0.04904389411733719
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.04904389411733719
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.04904389411733719
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000915751	0.04904389411733719
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 103	0.000915751	0.04904389411733719
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.04904389411733719
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000915751	0.04904389411733719
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.04904389411733719
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000915751	0.04904389411733719
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.04904389411733719
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.04904389411733719
COWDEN SYNDROME 5; CWS5	0.000915751	0.04904389411733719
HYPOPHOSPHATASIA, INFANTILE	0.000915751	0.04904389411733719
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000915751	0.04904389411733719
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.04904389411733719
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.04904389411733719
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000915751	0.04904389411733719
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.04904389411733719
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.04904389411733719
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.04904389411733719
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.04904389411733719
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000915751	0.04904389411733719
AUTISM	0.000915751	0.04904389411733719
CRANIOSYNOSTOSIS 2	0.000915751	0.04904389411733719
CROUZON SYNDROME	0.000915751	0.04904389411733719
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.04904389411733719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000915751	0.04904389411733719
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.04904389411733719
POTOCKI-SHAFFER SYNDROME	0.000915751	0.04904389411733719
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000915751	0.04904389411733719
DESANTO-SHINAWI SYNDROME	0.000915751	0.04904389411733719
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.04904389411733719
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.04904389411733719
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.04904389411733719
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.04904389411733719
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.04904389411733719
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.04904389411733719
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000915751	0.04904389411733719
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000915751	0.04904389411733719
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000915751	0.04904389411733719
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.04904389411733719
Helsmoortel-van der Aa syndrome	0.000915751	0.04904389411733719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000915751	0.04904389411733719
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.04904389411733719
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.000915751	0.04904389411733719
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.04904389411733719
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.04904389411733719
GRACILE BONE DYSPLASIA; GCLEB	0.000915751	0.04904389411733719
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000915751	0.04904389411733719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000915751	0.04904389411733719
SHASHI-PENA SYNDROME; SHAPNS	0.000915751	0.04904389411733719
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.04904389411733719
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000915751	0.04904389411733719
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.04904389411733719
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.04904389411733719
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000915751	0.04904389411733719
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.000915751	0.04904389411733719
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000915751	0.04904389411733719
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.04904389411733719
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.04904389411733719
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.04904389411733719
TENORIO SYNDROME; TNORS	0.000915751	0.04904389411733719
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000915751	0.04904389411733719
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.04904389411733719
GRISCELLI SYNDROME, TYPE 1	0.000915751	0.04904389411733719
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.04904389411733719
CORNELIA DE LANGE SYNDROME 3	0.000915751	0.04904389411733719
PRADER-WILLI SYNDROME; PWS	0.000915751	0.04904389411733719
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000915751	0.04904389411733719
ATKIN-FLAITZ SYNDROME	0.000915751	0.04904389411733719
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.04904389411733719
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000915751	0.04904389411733719
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000915751	0.04904389411733719
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.04904389411733719
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000915751	0.04904389411733719
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000915751	0.04904389411733719
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.04904389411733719
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000915751	0.04904389411733719
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000915751	0.04904389411733719
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.04904389411733719
FOLATE MALABSORPTION, HEREDITARY	0.000915751	0.04904389411733719
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.04904389411733719
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000915751	0.04904389411733719
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.04904389411733719
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000915751	0.04904389411733719
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.04904389411733719
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.04904389411733719
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000915751	0.04904389411733719
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000915751	0.04904389411733719
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000915751	0.04904389411733719
LANDAU-KLEFFNER SYNDROME	0.000915751	0.04904389411733719
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000915751	0.04904389411733719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000915751	0.04904389411733719
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000915751	0.04904389411733719
DIAMINOPENTANURIA	0.000915751	0.04904389411733719
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.04904389411733719
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.04904389411733719
MEND SYNDROME; MEND	0.000915751	0.04904389411733719
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000915751	0.04904389411733719
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000915751	0.04904389411733719
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000915751	0.04904389411733719
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.04904389411733719
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000915751	0.04904389411733719
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.04904389411733719
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000915751	0.04904389411733719
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000915751	0.04904389411733719
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.04904389411733719
RAMON SYNDROME	0.000915751	0.04904389411733719
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000915751	0.04904389411733719
THREONINEMIA	0.000915751	0.04904389411733719
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000915751	0.04904389411733719
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000915751	0.04904389411733719
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000915751	0.04904389411733719
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000915751	0.04904389411733719
Cerebral creatine deficiency syndrome 2	0.000915751	0.04904389411733719
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.04904389411733719
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.04904389411733719
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.04904389411733719
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.04904389411733719
SMITH-KINGSMORE SYNDROME; SKS	0.000915751	0.04904389411733719
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.04904389411733719
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.04904389411733719
HUNTINGTON DISEASE; HD	0.000915751	0.04904389411733719
ARGININOSUCCINIC ACIDURIA	0.000915751	0.04904389411733719
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.04904389411733719
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000915751	0.04904389411733719
PALLISTER-HALL SYNDROME	0.000915751	0.04904389411733719
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000915751	0.04904389411733719
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000915751	0.04904389411733719
HARTNUP DISORDER	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000915751	0.04904389411733719
SHUKLA-VERNON SYNDROME; SHUVER	0.000915751	0.04904389411733719
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000915751	0.04904389411733719
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000915751	0.04904389411733719
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000915751	0.04904389411733719
PROPIONIC ACIDEMIA	0.000915751	0.04904389411733719
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000915751	0.04904389411733719
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.04904389411733719
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000915751	0.04904389411733719
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.04904389411733719
Adrenoleukodystrophy	0.000915751	0.04904389411733719
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.04904389411733719
OHDO SYNDROME	0.000915751	0.04904389411733719
GAUCHER DISEASE, TYPE II	0.000915751	0.04904389411733719
HYPER-BETA-ALANINEMIA	0.000915751	0.04904389411733719
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.04904389411733719
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.04904389411733719
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000915751	0.04904389411733719
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.04904389411733719
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.000915751	0.04904389411733719
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.04904389411733719
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000915751	0.04904389411733719
IMMUNODEFICIENCY 47	0.000915751	0.04904389411733719
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000915751	0.04904389411733719
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.04904389411733719
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.04904389411733719
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.04904389411733719
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000915751	0.04904389411733719
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000915751	0.04904389411733719
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.04904389411733719
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.04904389411733719
LISSENCEPHALY 5; LIS5	0.000915751	0.04904389411733719
HOLOPROSENCEPHALY 7	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.04904389411733719
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.04904389411733719
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.04904389411733719
COFFIN-SIRIS SYNDROME 2; CSS2	0.000915751	0.04904389411733719
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000915751	0.04904389411733719
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.04904389411733719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000915751	0.04904389411733719
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.04904389411733719
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000915751	0.04904389411733719
2q33.1 deletion syndrome	0.000915751	0.04904389411733719
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.04904389411733719
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000915751	0.04904389411733719
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.04904389411733719
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.04904389411733719
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000915751	0.04904389411733719
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000915751	0.04904389411733719
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.04904389411733719
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000915751	0.04904389411733719
Muenke syndrome	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.04904389411733719
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000915751	0.04904389411733719
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.04904389411733719
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.000915751	0.04904389411733719
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.04904389411733719
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.000915751	0.04904389411733719
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.04904389411733719
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.04904389411733719
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000915751	0.04904389411733719
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.04904389411733719
KETOADIPICACIDURIA	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.04904389411733719
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000915751	0.04904389411733719
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000915751	0.04904389411733719
SMITH-MAGENIS SYNDROME; SMS	0.000915751	0.04904389411733719
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000915751	0.04904389411733719
CHROMOSOME 5Q12 DELETION SYNDROME	0.000915751	0.04904389411733719
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000915751	0.04904389411733719
RETT SYNDROME, CONGENITAL VARIANT	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000915751	0.04904389411733719
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.000915751	0.04904389411733719
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000915751	0.04904389411733719
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000915751	0.04904389411733719
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000915751	0.04904389411733719
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.04904389411733719
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000915751	0.04904389411733719
LISSENCEPHALY 1; LIS1	0.000915751	0.04904389411733719
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.000915751	0.04904389411733719
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.04904389411733719
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.04904389411733719
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000915751	0.04904389411733719
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.04904389411733719
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000915751	0.04904389411733719
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.04904389411733719
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000915751	0.04904389411733719
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000915751	0.04904389411733719
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000915751	0.04904389411733719
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.04904389411733719
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.04904389411733719
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000915751	0.04904389411733719
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.04904389411733719
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000915751	0.04904389411733719
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000915751	0.04904389411733719
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.04904389411733719
TEMTAMY SYNDROME; TEMTYS	0.000915751	0.04904389411733719
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.04904389411733719
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.04904389411733719
PEHO SYNDROME; PEHO	0.000915751	0.04904389411733719
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.04904389411733719
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000915751	0.04904389411733719
GURRIERI SYNDROME	0.000915751	0.04904389411733719
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.04904389411733719
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.04904389411733719
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.04904389411733719
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.04904389411733719
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000915751	0.04904389411733719
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.04904389411733719
#614483 PORENCEPHALY 2; POREN2	0.000915751	0.04904389411733719
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000915751	0.04904389411733719
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000915751	0.04904389411733719
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.04904389411733719
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000915751	0.04904389411733719
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.04904389411733719
NIEMANN-PICK DISEASE, TYPE C2	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000915751	0.04904389411733719
PAPILLORENAL SYNDROME	0.000915751	0.04904389411733719
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.04904389411733719
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.04904389411733719
FLYNN-AIRD SYNDROME	0.000915751	0.04904389411733719
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.04904389411733719
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000915751	0.04904389411733719
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.04904389411733719
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000915751	0.04904389411733719
GABA-TRANSAMINASE DEFICIENCY	0.000915751	0.04904389411733719
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.04904389411733719
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000915751	0.04904389411733719
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.04904389411733719
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000915751	0.04904389411733719
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.04904389411733719
STURGE-WEBER SYNDROME	0.000915751	0.04904389411733719
NOONAN SYNDROME 7; NS7	0.000915751	0.04904389411733719
COFFIN-SIRIS SYNDROME 8; CSS8	0.000915751	0.04904389411733719
KUFOR-RAKEB SYNDROME	0.000915751	0.04904389411733719
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.04904389411733719
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000915751	0.04904389411733719
ZIMMERMANN-LABAND SYNDROME 1	0.000915751	0.04904389411733719
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000915751	0.04904389411733719
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.04904389411733719
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000915751	0.04904389411733719
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000915751	0.04904389411733719
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.04904389411733719
WAISMAN SYNDROME; WSMN	0.000915751	0.04904389411733719
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000915751	0.04904389411733719
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000915751	0.04904389411733719
DARIER-WHITE DISEASE; DAR	0.000915751	0.04904389411733719
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000915751	0.04904389411733719
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.04904389411733719
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000915751	0.04904389411733719
TIMOTHY SYNDROME; TS	0.000915751	0.04904389411733719
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000915751	0.04904389411733719
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.04904389411733719
1p36 microdeletion syndrome	0.000915751	0.04904389411733719
XQ25 DUPLICATION SYNDROME	0.000915751	0.04904389411733719
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000915751	0.04904389411733719
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.04904389411733719
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.04904389411733719
HYPERLYSINEMIA, TYPE I	0.000915751	0.04904389411733719
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000915751	0.04904389411733719
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.04904389411733719
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000915751	0.04904389411733719
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000915751	0.04904389411733719
EPILEPSY, READING	0.000915751	0.04904389411733719
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.04904389411733719
WEBB-DATTANI SYNDROME; WEDAS	0.000915751	0.04904389411733719
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.04904389411733719
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000915751	0.04904389411733719
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000915751	0.04904389411733719
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.04904389411733719
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000915751	0.04904389411733719
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000915751	0.04904389411733719
LUSCAN-LUMISH SYNDROME; LLS	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000915751	0.04904389411733719
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000915751	0.04904389411733719
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000915751	0.04904389411733719
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.04904389411733719
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.04904389411733719
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.04904389411733719
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.04904389411733719
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.04904389411733719
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000915751	0.04904389411733719
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.04904389411733719
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000915751	0.04904389411733719
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.04904389411733719
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000915751	0.04904389411733719
CHROMOSOME 2q37 DELETION SYNDROME	0.000915751	0.04904389411733719
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.04904389411733719
RETT SYNDROME; RTT	0.000915751	0.04904389411733719
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.04904389411733719
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.04904389411733719
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.000915751	0.04904389411733719
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000915751	0.04904389411733719
IMMUNODEFICIENCY 49; IMD49	0.000915751	0.04904389411733719
PYRUVATE CARBOXYLASE DEFICIENCY	0.000915751	0.04904389411733719
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.04904389411733719
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.04904389411733719
DIGEORGE SYNDROME; DGS	0.000915751	0.04904389411733719
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.04904389411733719
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000915751	0.04904389411733719
CITRULLINEMIA, CLASSIC	0.000915751	0.04904389411733719
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.000915751	0.04904389411733719
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000915751	0.04904389411733719
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.04904389411733719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000915751	0.04904389411733719
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000915751	0.04904389411733719
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.04904389411733719
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.04904389411733719
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000915751	0.04904389411733719
EPILEPSY-TELANGIECTASIA	0.000915751	0.04904389411733719
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000915751	0.04904389411733719
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.04904389411733719
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000915751	0.04904389411733719
